{
  "SimulationMappings": [
    {
      "Project": "Midazolam",
      "Simulation": "iv 0.001 mg (5 min)",
      "Path": "Midazolam/iv 0.001 mg (5 min)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 0.05 mg/kg (2 min)",
      "Path": "Midazolam/iv 0.05 mg_kg (2 min)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 0.05 mg/kg (30 min)",
      "Path": "Midazolam/iv 0.05 mg_kg (30 min)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 0.05 mg/kg (bolus)",
      "Path": "Midazolam/iv 0.05 mg_kg (bolus)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 0.075 mg/kg (1 min)",
      "Path": "Midazolam/iv 0.075 mg_kg (1 min)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 0.15 mg/kg (bolus)",
      "Path": "Midazolam/iv 0.15 mg_kg (bolus)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 1 mg (5 min)",
      "Path": "Midazolam/iv 1 mg (5 min)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 1 mg (bolus)",
      "Path": "Midazolam/iv 1 mg (bolus)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 2 mg (2 min)",
      "Path": "Midazolam/iv 2 mg (2 min)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 2 mg (bolus)",
      "Path": "Midazolam/iv 2 mg (bolus)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 5 mg (30 sec)",
      "Path": "Midazolam/iv 5 mg (30 sec)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "iv 5 mg (bolus)",
      "Path": "Midazolam/iv 5 mg (bolus)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 0.003 mg (solution)",
      "Path": "Midazolam/po 0.003 mg (solution)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 0.075 mg (solution)",
      "Path": "Midazolam/po 0.075 mg (solution)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 0.075 mg/kg (syrup)",
      "Path": "Midazolam/po 0.075 mg_kg (syrup)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 1 mg (solution)",
      "Path": "Midazolam/po 1 mg (solution)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 10 mg (tablet)",
      "Path": "Midazolam/po 10 mg (tablet)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 15 mg (tablet)",
      "Path": "Midazolam/po 15 mg (tablet)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 2 mg (solution)",
      "Path": "Midazolam/po 2 mg (solution)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 20 mg (tablet)",
      "Path": "Midazolam/po 20 mg (tablet)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 3 mg (solution)",
      "Path": "Midazolam/po 3 mg (solution)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 4 mg (solution)",
      "Path": "Midazolam/po 4 mg (solution)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 40 mg (tablet)",
      "Path": "Midazolam/po 40 mg (tablet)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 5 mg (solution)",
      "Path": "Midazolam/po 5 mg (solution)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 6 mg (solution)",
      "Path": "Midazolam/po 6 mg (solution)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 7.5 mg (solution)",
      "Path": "Midazolam/po 7.5 mg (solution)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 8 mg (solution)",
      "Path": "Midazolam/po 8 mg (solution)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 7.5 mg (tablet)",
      "Path": "Midazolam/po 7.5 mg (tablet)"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 10 mg (solution)",
      "Path": "Midazolam/po 10 mg (solution)/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 15 mg (tablet) - with high-fat breakfast",
      "Path": "Midazolam/po 15 mg (tablet) - with high-fat breakfast/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 15 mg (tablet) - with 1 h before high-fat breakfast",
      "Path": "Midazolam/po 15 mg (tablet) - with 1 h before high-fat breakfast/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 15 mg (tablet) - with 1h after high-fat breakfast",
      "Path": "Midazolam/po 15 mg (tablet) - with 1h after high-fat breakfast/"
    },
    {
      "Project": "Midazolam",
      "Simulation": "po 2.5 mg (solution)",
      "Path": "Midazolam/po 2.5 mg (solution)"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "100 mg IV SD",
      "Path": "Itraconazole/100 mg IV SD/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 100 mg MD OD caps fed 2",
      "Path": "Itraconazole/po 100 mg MD OD caps fed 2/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 100 mg MD OD caps fed 1",
      "Path": "Itraconazole/po 100 mg MD OD caps fed 1/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 100 mg SD caps fast",
      "Path": "Itraconazole/po 100 mg SD caps fast/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 100 mg SD caps fed",
      "Path": "Itraconazole/po 100 mg SD caps fed/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 200 mg MD BID caps fed 1",
      "Path": "Itraconazole/po 200 mg MD BID caps fed 1/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 200 mg MD BID caps fed 2",
      "Path": "Itraconazole/po 200 mg MD BID caps fed 2/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 200 mg SD caps fast",
      "Path": "Itraconazole/po 200 mg SD caps fast/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 200 mg SD caps fed",
      "Path": "Itraconazole/po 200 mg SD caps fed/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 100 mg MD OD sol fast",
      "Path": "Itraconazole/po 100 mg MD OD sol fast/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 100 mg SD sol fast",
      "Path": "Itraconazole/po 100 mg SD sol fast/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 100 mg SD  sol fed",
      "Path": "Itraconazole/po 100 mg SD  sol fed/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 200 mg MD OD sol fast",
      "Path": "Itraconazole/po 200 mg MD OD sol fast/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 200 mg MD OD caps fed",
      "Path": "Itraconazole/po 200 mg MD OD caps fed/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 200 mg SD sol fed",
      "Path": "Itraconazole/po 200 mg SD sol fed/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 200 mg MD OD sol fed",
      "Path": "Itraconazole/po 200 mg MD OD sol fed/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "Abdel-Rahman2007 0.5-2yr",
      "Path": "Itraconazole/Abdel-Rahman2007 0.5-2yr"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "Abdel-Rahman2007 12-16yr",
      "Path": "Itraconazole/Abdel-Rahman2007 12-16yr/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "Abdel-Rahman2007 2-6yr",
      "Path": "Itraconazole/Abdel-Rahman2007 2-6yr/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "Abdel-Rahman2007 6-12yr",
      "Path": "Itraconazole/Abdel-Rahman2007 6-12yr/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "200 mg IV MD",
      "Path": "Itraconazole/200 mg IV MD/"
    },
    {
      "Project": "Itraconazole",
      "Simulation": "po 200 mg MD OD caps fast",
      "Path": "Itraconazole/po 200 mg MD OD caps fast/"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin iv 600 mg (3 h) MD OD (7 days)",
      "Path": "Rifampicin/Rifampicin iv 600 mg (3 h) MD OD (7 days)/"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin iv 300 mg (0.5 h)",
      "Path": "Rifampicin/Rifampicin iv 300 mg (0.5 h)"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin iv 300 mg (3 h)",
      "Path": "Rifampicin/Rifampicin iv 300 mg (3 h)/"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin iv 450 mg (3 h)",
      "Path": "Rifampicin/Rifampicin iv 450 mg (3 h)/"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin iv 600 mg (0.5 h)",
      "Path": "Rifampicin/Rifampicin iv 600 mg (0.5 h)"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin iv 600 mg (3 h)",
      "Path": "Rifampicin/Rifampicin iv 600 mg (3 h)/"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin po 450 mg MD OD (7 days)",
      "Path": "Rifampicin/Rifampicin po 450 mg MD OD (7 days)/"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
      "Path": "Rifampicin/Rifampicin po 600 mg MD OD (7 days)/"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin po 300 mg",
      "Path": "Rifampicin/Rifampicin po 300 mg/"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin po 450 mg",
      "Path": "Rifampicin/Rifampicin po 450 mg/"
    },
    {
      "Project": "Rifampicin",
      "Simulation": "Rifampicin po 600 mg",
      "Path": "Rifampicin/Rifampicin po 600 mg/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
      "Path": "Itraconazole-Midazolam-DDI/DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
      "Path": "Itraconazole-Midazolam-DDI/DDI Treatment - Itraconazole_Midazolam - Olkkola 1996/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Backman 1998",
      "Path": "Itraconazole-Midazolam-DDI/DDI Control - Midazolam - Backman 1998/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
      "Path": "Itraconazole-Midazolam-DDI/DDI Treatment - Itraconazole_Midazolam - Backman 1998/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Olkkola 1994",
      "Path": "Itraconazole-Midazolam-DDI/DDI Control - Midazolam - Olkkola 1994/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
      "Path": "Itraconazole-Midazolam-DDI/DDI Treatment - Itraconazole_Midazolam - Olkkola 1994/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Ahonen 1995",
      "Path": "Itraconazole-Midazolam-DDI/DDI Control - Midazolam - Ahonen 1995/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
      "Path": "Itraconazole-Midazolam-DDI/DDI Treatment - Itraconazole_Midazolam - Ahonen 1995/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Templeton 2010",
      "Path": "Itraconazole-Midazolam-DDI/DDI Control - Midazolam - Templeton 2010/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
      "Path": "Itraconazole-Midazolam-DDI/DDI Treatment - Itraconazole_Midazolam - Templeton 2010 (50 mg)/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
      "Path": "Itraconazole-Midazolam-DDI/DDI Treatment - Itraconazole_Midazolam - Templeton 2010 (200 mg)/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
      "Path": "Itraconazole-Midazolam-DDI/DDI Treatment - Itraconazole_Midazolam - Templeton 2010 (400 mg)/"
    },
    {
      "Project": "Itraconazole-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
      "Path": "Itraconazole-Midazolam-DDI/DDI Control - Midazolam - Olkkola 1996 (iv, day 4)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Backman 1996",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Backman 1996/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Backman 1998/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Backman 1998",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Backman 1998/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Backman 1996/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Chung 2006/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Chung 2006",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Chung 2006/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Eap 2004/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Eap 2004 (0.075 mg)"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Eap 2004 (7.5 mg)"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Gorski 2003 (iv)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Gorski 2003 (po)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Gorski 2003 (iv)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Gorski 2003 (iv)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Gorski 2003 (po)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Gorski 2003 (po)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Gurley 2006",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Gurley 2006/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Gurley 2008",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Gurley 2008/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Gurley 2008/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Gurley 2006/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Kharasch 2004/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Kharasch 2004 (iv)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Kharasch 2004 (iv)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Kharasch 2004 (po)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Kharasch 2004 (po)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Link 2008 (po)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Link 2008 (iv)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Link 2008 (po)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Link 2008 (po)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Link 2008 (iv)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Link 2008 (iv)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Phimmasone 2001/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Phimmasone 2001",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Phimmasone 2001/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Reitman 2011/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Szalat 2007/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Szalat 2007",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Szalat 2007/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Kharasch 2011 (RIF @ 5 mg)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Kharasch 2011 (RIF @ 10 mg)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Kharasch 2011 (RIF @ 25 mg)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Kharasch 2011 (RIF @ 75 mg)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Kharasch 2011 (iv)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Kharasch 2011 (po)/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Control - Midazolam - Kharasch 1997",
      "Path": "Rifampicin-Midazolam-DDI/DDI Control - Midazolam - Kharasch 1997/"
    },
    {
      "Project": "Rifampicin-Midazolam-DDI",
      "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
      "Path": "Rifampicin-Midazolam-DDI/DDI Treatment - Rifampicin_Midazolam - Kharasch 1997/"
    }
  ],
  "ObservedDataSets": [
    {
      "Id": "Bornemann 1986 - 1 h after a meal - Midazolam - PO - 15 mg - Plasma - agg. (n=18)",
      "Path": "ObservedData/Bornemann 1986 - 1 h after a meal - Midazolam - PO - 15 mg - Plasma - agg. (n=18).csv"
    },
    {
      "Id": "Olkkola 1993 - po Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1993 - po Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Allonen 1981 - oral - Midazolam - PO - 15 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Allonen 1981 - oral - Midazolam - PO - 15 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Allonen 1981 - iv - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Allonen 1981 - iv - Midazolam - IV - 0.075 mg_kg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
      "Path": "ObservedData/Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg_kg - Plasma - agg. (n=18).csv"
    },
    {
      "Id": "Gorski 1998 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16)",
      "Path": "ObservedData/Gorski 1998 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16).csv"
    },
    {
      "Id": "Gorski 1998 - po with Perpetrator (Clarithromycin) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16)",
      "Path": "ObservedData/Gorski 1998 - po with Perpetrator (Clarithromycin) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16).csv"
    },
    {
      "Id": "Gorski 1998 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)",
      "Path": "ObservedData/Gorski 1998 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg_kg - Whole Blood - agg. (n=16).csv"
    },
    {
      "Id": "Gorski 1998 - iv with Perpetrator (Clarithromycin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)",
      "Path": "ObservedData/Gorski 1998 - iv with Perpetrator (Clarithromycin) - Midazolam - IV - 0.05 mg_kg - Whole Blood - agg. (n=16).csv"
    },
    {
      "Id": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)",
      "Path": "ObservedData/Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52).csv"
    },
    {
      "Id": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
      "Path": "ObservedData/Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg_kg - Whole Blood - agg. (n=52).csv"
    },
    {
      "Id": "Greenblat 1984 - iv - f, 136kg, 36y (obese female) - Midazolam - IV - 5 mg - Plasma - typical (n=10)",
      "Path": "ObservedData/Greenblat 1984 - iv - f, 136kg, 36y (obese female) - Midazolam - IV - 5 mg - Plasma - typical (n=10).csv"
    },
    {
      "Id": "Greenblat 1984 - iv - f, 61kg, 37y (normal female) - Midazolam - IV - 5 mg - Plasma - typical (n=10)",
      "Path": "ObservedData/Greenblat 1984 - iv - f, 61kg, 37y (normal female) - Midazolam - IV - 5 mg - Plasma - typical (n=10).csv"
    },
    {
      "Id": "Greenblat 1984 - iv - m, 70kg, 32y (young male) - Midazolam - IV - 5 mg - Plasma - typical (n=10)",
      "Path": "ObservedData/Greenblat 1984 - iv - m, 70kg, 32y (young male) - Midazolam - IV - 5 mg - Plasma - typical (n=10).csv"
    },
    {
      "Id": "Greenblat 1984 - iv - m, 80kg, 70y (elderly male) - Midazolam - IV - 5 mg - Plasma - typical (n=9)",
      "Path": "ObservedData/Greenblat 1984 - iv - m, 80kg, 70y (elderly male) - Midazolam - IV - 5 mg - Plasma - typical (n=9).csv"
    },
    {
      "Id": "Greenblat 1984 - po - f, 136kg, 36y (obese female) - Midazolam - PO - 10 mg - Plasma - typical (n=10)",
      "Path": "ObservedData/Greenblat 1984 - po - f, 136kg, 36y (obese female) - Midazolam - PO - 10 mg - Plasma - typical (n=10).csv"
    },
    {
      "Id": "Greenblat 1984 - po - f, 61kg, 37y (normal female) - Midazolam - PO - 10 mg - Plasma - typical (n=10)",
      "Path": "ObservedData/Greenblat 1984 - po - f, 61kg, 37y (normal female) - Midazolam - PO - 10 mg - Plasma - typical (n=10).csv"
    },
    {
      "Id": "Greenblat 1984 - po - m, 70kg, 32y (young male) - Midazolam - PO - 10 mg - Plasma - typical (n=10)",
      "Path": "ObservedData/Greenblat 1984 - po - m, 70kg, 32y (young male) - Midazolam - PO - 10 mg - Plasma - typical (n=10).csv"
    },
    {
      "Id": "Greenblat 1984 - po - m, 80kg, 70y (elderly male) - Midazolam - PO - 10 mg - Plasma - typical (n=9)",
      "Path": "ObservedData/Greenblat 1984 - po - m, 80kg, 70y (elderly male) - Midazolam - PO - 10 mg - Plasma - typical (n=9).csv"
    },
    {
      "Id": "Greenblat 2003 - Control (Perpetrator Placebo) - Midazolam - PO - 6 mg - Plasma - agg. (n=25)",
      "Path": "ObservedData/Greenblat 2003 - Control (Perpetrator Placebo) - Midazolam - PO - 6 mg - Plasma - agg. (n=25).csv"
    },
    {
      "Id": "Greenblat 2003 - with Perpetrator (GFJ) - Midazolam - PO - 6 mg - Plasma - agg. (n=25)",
      "Path": "ObservedData/Greenblat 2003 - with Perpetrator (GFJ) - Midazolam - PO - 6 mg - Plasma - agg. (n=25).csv"
    },
    {
      "Id": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
      "Path": "ObservedData/Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19).csv"
    },
    {
      "Id": "Gurley 2006 - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
      "Path": "ObservedData/Gurley 2006 - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19).csv"
    },
    {
      "Id": "Gurley 2006 - Control pre-Black cohosh (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
      "Path": "ObservedData/Gurley 2006 - Control pre-Black cohosh (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19).csv"
    },
    {
      "Id": "Gurley 2006 - Control pre-Milk thistle (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
      "Path": "ObservedData/Gurley 2006 - Control pre-Milk thistle (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19).csv"
    },
    {
      "Id": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Gurley 2008a - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Gurley 2008a - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Gurley 2008a - Control pre-Goldenseal (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Gurley 2008a - Control pre-Goldenseal (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Gurley 2008a - Control pre-Kava kava (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Gurley 2008a - Control pre-Kava kava (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. CH.B. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - iv 0.15 mg_kg - Indiv. CH.B. - Midazolam - IV - 0.15 mg_kg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. K.M. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - iv 0.15 mg_kg - Indiv. K.M. - Midazolam - IV - 0.15 mg_kg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. E.Sch. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - iv 0.15 mg_kg - Indiv. E.Sch. - Midazolam - IV - 0.15 mg_kg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. R.H. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - iv 0.15 mg_kg - Indiv. R.H. - Midazolam - IV - 0.15 mg_kg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. A.St. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - iv 0.15 mg_kg - Indiv. A.St. - Midazolam - IV - 0.15 mg_kg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. O.A. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - iv 0.15 mg_kg - Indiv. O.A. - Midazolam - IV - 0.15 mg_kg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 10 mg - Indiv. K.M. - Midazolam - PO - 10 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 10 mg - Indiv. K.M. - Midazolam - PO - 10 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 10 mg - Indiv. O.A. - Midazolam - PO - 10 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 10 mg - Indiv. O.A. - Midazolam - PO - 10 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 10 mg - Indiv. R.H. - Midazolam - PO - 10 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 10 mg - Indiv. R.H. - Midazolam - PO - 10 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 20 mg - Indiv. A.St. - Midazolam - PO - 20 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 20 mg - Indiv. A.St. - Midazolam - PO - 20 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 20 mg - Indiv. CH.B. - Midazolam - PO - 20 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 20 mg - Indiv. CH.B. - Midazolam - PO - 20 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 20 mg - Indiv. E.Sch. - Midazolam - PO - 20 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 20 mg - Indiv. E.Sch. - Midazolam - PO - 20 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 20 mg - Indiv. K.M. - Midazolam - PO - 20 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 20 mg - Indiv. K.M. - Midazolam - PO - 20 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 20 mg - Indiv. O.A. - Midazolam - PO - 20 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 20 mg - Indiv. O.A. - Midazolam - PO - 20 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 20 mg - Indiv. R.H. - Midazolam - PO - 20 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 20 mg - Indiv. R.H. - Midazolam - PO - 20 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 40 mg - Indiv. A.St. - Midazolam - PO - 40 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 40 mg - Indiv. A.St. - Midazolam - PO - 40 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 40 mg - Indiv. CH.B. - Midazolam - PO - 40 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 40 mg - Indiv. CH.B. - Midazolam - PO - 40 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Heizmann 1983 - po 40 mg - Indiv. E.Sch. - Midazolam - PO - 40 mg - Plasma - indiv.",
      "Path": "ObservedData/Heizmann 1983 - po 40 mg - Indiv. E.Sch. - Midazolam - PO - 40 mg - Plasma - indiv..csv"
    },
    {
      "Id": "Hohmann 2015 - iv 0.001 mg - Midazolam - IV - 0.001 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Hohmann 2015 - iv 0.001 mg - Midazolam - IV - 0.001 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Hohmann 2015 - iv 1 mg - Midazolam - IV - 1 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Hohmann 2015 - iv 1 mg - Midazolam - IV - 1 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Hohmann 2015 - po 0.003 mg - Midazolam - PO - 0.003 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Hohmann 2015 - po 0.003 mg - Midazolam - PO - 0.003 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Hohmann 2015 - po 3 mg - Midazolam - PO - 3 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Hohmann 2015 - po 3 mg - Midazolam - PO - 3 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Hyland 2009 - 3-mg oral dose (as fraction of dose) - Midazolam-N-Glucuronide - PO - 3 mg - Urine - agg. (n=6)",
      "Path": "ObservedData/Hyland 2009 - 3-mg oral dose (as fraction of dose) - Midazolam-N-Glucuronide - PO - 3 mg - Urine - agg. (n=6).csv"
    },
    {
      "Id": "Hyland 2009 - 1-mg i.v. dose (as fraction of dose) - Midazolam-N-Glucuronide - IV - 1 mg - Urine - agg. (n=6)",
      "Path": "ObservedData/Hyland 2009 - 1-mg i.v. dose (as fraction of dose) - Midazolam-N-Glucuronide - IV - 1 mg - Urine - agg. (n=6).csv"
    },
    {
      "Id": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
      "Path": "ObservedData/Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9).csv"
    },
    {
      "Id": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Majumdar 2007 - po Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Majumdar 2007 - po Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Majumdar 2007 - po with Perpetrator (Aprepitant) - Midazolam - IV - 2 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Majumdar 2007 - po with Perpetrator (Aprepitant) - Midazolam - IV - 2 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Okudaira 2007 - EM 0 Control (Perpetrator Placebo) - Midazolam - PO - 2.5 (actually 5) mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Okudaira 2007 - EM 0 Control (Perpetrator Placebo) - Midazolam - PO - 2.5 (actually 5) mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Olkkola 1993 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Olkkola 1993 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg_kg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
      "Path": "ObservedData/Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11).csv"
    },
    {
      "Id": "Saari 2006 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Saari 2006 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Saari 2006 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Saari 2006 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg_kg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Schwagmeier 1998 - iv administration - Midazolam - IV - 5 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Schwagmeier 1998 - iv administration - Midazolam - IV - 5 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Smith 1981 - iv 5 mg - Midazolam - IV - 5 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Smith 1981 - iv 5 mg - Midazolam - IV - 5 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Smith 1981 - oral solution 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Smith 1981 - oral solution 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Smith 1981 - oral tablet 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Smith 1981 - oral tablet 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
      "Path": "ObservedData/Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg_kg - Plasma - agg. (n=3).csv"
    },
    {
      "Id": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Tham 2006 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=28)",
      "Path": "ObservedData/Tham 2006 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=28).csv"
    },
    {
      "Id": "Thummel 1996 - iv - female - Midazolam - IV - 1 mg - Urine - agg. (n=10)",
      "Path": "ObservedData/Thummel 1996 - iv - female - Midazolam - IV - 1 mg - Urine - agg. (n=10).csv"
    },
    {
      "Id": "Thummel 1996 - iv - male - Midazolam - IV - 1 mg - Urine - agg. (n=10)",
      "Path": "ObservedData/Thummel 1996 - iv - male - Midazolam - IV - 1 mg - Urine - agg. (n=10).csv"
    },
    {
      "Id": "Thummel 1996 - po - female - Midazolam - PO - 2 mg - Urine - agg. (n=10)",
      "Path": "ObservedData/Thummel 1996 - po - female - Midazolam - PO - 2 mg - Urine - agg. (n=10).csv"
    },
    {
      "Id": "Thummel 1996 - po - male - Midazolam - PO - 2 mg - Urine - agg. (n=10)",
      "Path": "ObservedData/Thummel 1996 - po - male - Midazolam - PO - 2 mg - Urine - agg. (n=10).csv"
    },
    {
      "Id": "Yeates 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Yeates 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Zimmermann 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Zimmermann 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg_kg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)",
      "Path": "ObservedData/Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13).csv"
    },
    {
      "Id": "Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21)",
      "Path": "ObservedData/Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21).csv"
    },
    {
      "Id": "Swart 2002 - day 5 Control (Perpetrator Placebo) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Swart 2002 - day 5 Control (Perpetrator Placebo) - Midazolam - IV - 0.075 mg_kg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Bornemann 1986 - 1 h before a meal - Midazolam - PO - 15 mg - Plasma - agg. (n=18)",
      "Path": "ObservedData/Bornemann 1986 - 1 h before a meal - Midazolam - PO - 15 mg - Plasma - agg. (n=18).csv"
    },
    {
      "Id": "Bornemann 1986 - fasting condition - Midazolam - PO - 15 mg - Plasma - agg. (n=18)",
      "Path": "ObservedData/Bornemann 1986 - fasting condition - Midazolam - PO - 15 mg - Plasma - agg. (n=18).csv"
    },
    {
      "Id": "Bornemann 1986 - with a meal - Midazolam - PO - 15 mg - Plasma - agg. (n=18)",
      "Path": "ObservedData/Bornemann 1986 - with a meal - Midazolam - PO - 15 mg - Plasma - agg. (n=18).csv"
    },
    {
      "Id": "Darwish 2008 - iv - Midazolam - IV - 2 mg - Plasma - agg. (n=24)",
      "Path": "ObservedData/Darwish 2008 - iv - Midazolam - IV - 2 mg - Plasma - agg. (n=24).csv"
    },
    {
      "Id": "Darwish 2008 - oral - Midazolam - PO - 5 mg - Plasma - agg. (n=24)",
      "Path": "ObservedData/Darwish 2008 - oral - Midazolam - PO - 5 mg - Plasma - agg. (n=24).csv"
    },
    {
      "Id": "Barone 1993 - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
      "Path": "ObservedData/Barone 1993 - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=28).csv"
    },
    {
      "Id": "Barone 1993 - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
      "Path": "ObservedData/Barone 1993 - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28).csv"
    },
    {
      "Id": "Barone 1993 - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
      "Path": "ObservedData/Barone 1993 - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28).csv"
    },
    {
      "Id": "Barone 1993 - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
      "Path": "ObservedData/Barone 1993 - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28).csv"
    },
    {
      "Id": "Barone 1993 - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
      "Path": "ObservedData/Barone 1993 - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28).csv"
    },
    {
      "Id": "Barone 1993 - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
      "Path": "ObservedData/Barone 1993 - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28).csv"
    },
    {
      "Id": "Barone 1998a - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
      "Path": "ObservedData/Barone 1998a - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27).csv"
    },
    {
      "Id": "Barone 1998a - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
      "Path": "ObservedData/Barone 1998a - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27).csv"
    },
    {
      "Id": "Barone 1998a - day 15 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
      "Path": "ObservedData/Barone 1998a - day 15 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27).csv"
    },
    {
      "Id": "Barone 1998a - day 15 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
      "Path": "ObservedData/Barone 1998a - day 15 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27).csv"
    },
    {
      "Id": "Barone 1998a - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
      "Path": "ObservedData/Barone 1998a - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27).csv"
    },
    {
      "Id": "Barone 1998a - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
      "Path": "ObservedData/Barone 1998a - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27).csv"
    },
    {
      "Id": "Barone 1998a - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
      "Path": "ObservedData/Barone 1998a - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27).csv"
    },
    {
      "Id": "Barone 1998a - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
      "Path": "ObservedData/Barone 1998a - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27).csv"
    },
    {
      "Id": "Barone 1998b - Solution - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)",
      "Path": "ObservedData/Barone 1998b - Solution - Itraconazole - PO - 200 mg - Plasma - agg. (n=30).csv"
    },
    {
      "Id": "Barone 1998b - Solution - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)",
      "Path": "ObservedData/Barone 1998b - Solution - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30).csv"
    },
    {
      "Id": "Barone 1998b - F05 Capsule - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)",
      "Path": "ObservedData/Barone 1998b - F05 Capsule - Itraconazole - PO - 200 mg - Plasma - agg. (n=30).csv"
    },
    {
      "Id": "Barone 1998b - F05 Capsule - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)",
      "Path": "ObservedData/Barone 1998b - F05 Capsule - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30).csv"
    },
    {
      "Id": "Hardin 1988 - A 100 mg OD (day 1) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)",
      "Path": "ObservedData/Hardin 1988 - A 100 mg OD (day 1) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5).csv"
    },
    {
      "Id": "Hardin 1988 - A 100 mg OD (day 7-15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)",
      "Path": "ObservedData/Hardin 1988 - A 100 mg OD (day 7-15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5).csv"
    },
    {
      "Id": "Hardin 1988 - A 100 mg OD (day 15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)",
      "Path": "ObservedData/Hardin 1988 - A 100 mg OD (day 15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5).csv"
    },
    {
      "Id": "Hardin 1988 - B 200 mg OD (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
      "Path": "ObservedData/Hardin 1988 - B 200 mg OD (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5).csv"
    },
    {
      "Id": "Hardin 1988 - B 200 mg OD (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
      "Path": "ObservedData/Hardin 1988 - B 200 mg OD (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5).csv"
    },
    {
      "Id": "Hardin 1988 - B 200 mg OD (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
      "Path": "ObservedData/Hardin 1988 - B 200 mg OD (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5).csv"
    },
    {
      "Id": "Hardin 1988 - C 200 mg BID (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
      "Path": "ObservedData/Hardin 1988 - C 200 mg BID (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5).csv"
    },
    {
      "Id": "Hardin 1988 - C 200 mg BID (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
      "Path": "ObservedData/Hardin 1988 - C 200 mg BID (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5).csv"
    },
    {
      "Id": "Hardin 1988 - C 200 mg BID (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
      "Path": "ObservedData/Hardin 1988 - C 200 mg BID (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5).csv"
    },
    {
      "Id": "Kivist 1997 - with Perpetrator (Itraconazole) - Itraconazole - PO - 100 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Kivist 1997 - with Perpetrator (Itraconazole) - Itraconazole - PO - 100 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Olkkola 1994 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Templeton 2008 - ITZ day 1 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2008 - ITZ day 1 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2008 - ITZ day 7 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2008 - ITZ day 7 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2008 - OH-ITZ day 1 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2008 - OH-ITZ day 1 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2008 - OH-ITZ day 7 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2008 - OH-ITZ day 7 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2008 - keto-ITZ day 1 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2008 - keto-ITZ day 1 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2008 - keto-ITZ day 7 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2008 - keto-ITZ day 7 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2008 - ND-OH-ITZ day 1 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2008 - ND-OH-ITZ day 1 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2008 - ND-OH-ITZ day 7 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2008 - ND-OH-ITZ day 7 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Van de Velde 1996 - Fasting ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Van de Velde 1996 - Fasting ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Van de Velde 1996 - Fasting OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Van de Velde 1996 - Fasting OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Van de Velde 1996 - Fed ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Van de Velde 1996 - Fed ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Van de Velde 1996 - Fed OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Van de Velde 1996 - Fed OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Van Peer 1989 - 100 mg Solution, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Van Peer 1989 - 100 mg Solution, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Van Peer 1989 - 100 mg Capsules, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Van Peer 1989 - 100 mg Capsules, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Van Peer 1989 - 100 mg Capsules, with food - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Van Peer 1989 - 100 mg Capsules, with food - Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Van Peer 1989 - 100 mg Capsules, with food, 15 days MD - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Van Peer 1989 - 100 mg Capsules, with food, 15 days MD - Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Heykants 1989 - iv 100 mg SD - Itraconazole - IV - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Heykants 1989 - iv 100 mg SD - Itraconazole - IV - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Heykants 1989 - po 100 mg SD fed - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Heykants 1989 - po 100 mg SD fed - Itraconazole - PO - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Heykants 1989 - po 100 mg SD (metabolite screening) - Itraconazole - PO - 100 mg - Plasma - agg. (n=24)",
      "Path": "ObservedData/Heykants 1989 - po 100 mg SD (metabolite screening) - Itraconazole - PO - 100 mg - Plasma - agg. (n=24).csv"
    },
    {
      "Id": "Heykants 1989 - po 100 mg SD (metabolite screening) - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=24)",
      "Path": "ObservedData/Heykants 1989 - po 100 mg SD (metabolite screening) - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=24).csv"
    },
    {
      "Id": "Heykants 1989 - po 100 mg MD OD - Itraconazole - PO - 100 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Heykants 1989 - po 100 mg MD OD - Itraconazole - PO - 100 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Heykants 1989 - po 100 mg MD OD - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Heykants 1989 - po 100 mg MD OD - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Miura 2010 - po 100 mg MD Japanese - Itraconazole - PO - 200 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Miura 2010 - po 100 mg MD Japanese - Itraconazole - PO - 200 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Miura 2010 - po 100 mg MD Japanese - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Miura 2010 - po 100 mg MD Japanese - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Gubbins 2004 - po 200 mg solution with water - Itraconazole - PO - 200 mg - Plasma - agg. (n=20)",
      "Path": "ObservedData/Gubbins 2004 - po 200 mg solution with water - Itraconazole - PO - 200 mg - Plasma - agg. (n=20).csv"
    },
    {
      "Id": "Gubbins 2004 - po 200 mg solution with water - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=20)",
      "Path": "ObservedData/Gubbins 2004 - po 200 mg solution with water - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=20).csv"
    },
    {
      "Id": "Gubbins 2007 - po 200 mg solution female with water - Itraconazole - PO - 200 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Gubbins 2007 - po 200 mg solution female with water - Itraconazole - PO - 200 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Gubbins 2007 - po 200 mg solution female with water - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Gubbins 2007 - po 200 mg solution female with water - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Gubbins 2007 - po 200 mg solution male with water - Itraconazole - PO - 200 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Gubbins 2007 - po 200 mg solution male with water - Itraconazole - PO - 200 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Gubbins 2007 - po 200 mg solution male with water - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Gubbins 2007 - po 200 mg solution male with water - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Uno 2006 - day 1 (Japanese) - Itraconazole - PO - 200 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Uno 2006 - day 1 (Japanese) - Itraconazole - PO - 200 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Uno 2006 - day 1 (Japanese) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Uno 2006 - day 1 (Japanese) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Uno 2006 - day 6 (Japanese) - Itraconazole - PO - 200 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Uno 2006 - day 6 (Japanese) - Itraconazole - PO - 200 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Uno 2006 - day 6 (Japanese) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Uno 2006 - day 6 (Japanese) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Bae 2011 - po 200 mg capsule with water (Korean) - Itraconazole - PO - 200 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Bae 2011 - po 200 mg capsule with water (Korean) - Itraconazole - PO - 200 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Bae 2011 - po 200 mg capsule with water (Korean) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Bae 2011 - po 200 mg capsule with water (Korean) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Bae 2011 - po 200 mg capsule with cola (Korean) - Itraconazole - PO - 200 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Bae 2011 - po 200 mg capsule with cola (Korean) - Itraconazole - PO - 200 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Bae 2011 - po 200 mg capsule with cola (Korean) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Bae 2011 - po 200 mg capsule with cola (Korean) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Bae 2011 - po 200 mg capsule with vit. C (Korean) - Itraconazole - PO - 200 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Bae 2011 - po 200 mg capsule with vit. C (Korean) - Itraconazole - PO - 200 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Bae 2011 - po 200 mg capsule with vit. C (Korean) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Bae 2011 - po 200 mg capsule with vit. C (Korean) - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Mouton 2006 - SAD_A 50 mg - Itraconazole - IV - 50 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Mouton 2006 - SAD_A 50 mg - Itraconazole - IV - 50 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Mouton 2006 - SAD_B 100 mg - Itraconazole - IV - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Mouton 2006 - SAD_B 100 mg - Itraconazole - IV - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Mouton 2006 - SAD_A 200 mg - Itraconazole - IV - 200 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Mouton 2006 - SAD_A 200 mg - Itraconazole - IV - 200 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Mouton 2006 - SAD_B 300 mg - Itraconazole - IV - 300 mg - Plasma - agg. (n=2)",
      "Path": "ObservedData/Mouton 2006 - SAD_B 300 mg - Itraconazole - IV - 300 mg - Plasma - agg. (n=2).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_A 100 mg - Itraconazole - IV - 100 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_A 100 mg - Itraconazole - IV - 100 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_B 200 mg - Itraconazole - IV - 200 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_B 200 mg - Itraconazole - IV - 200 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_C 300 mg - Itraconazole - IV - 300 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_C 300 mg - Itraconazole - IV - 300 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Itraconazole - IV - 200 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Itraconazole - IV - 200 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - SAD_A 50 mg - Hydroxy-Itraconazole - IV - 50 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Mouton 2006 - SAD_A 50 mg - Hydroxy-Itraconazole - IV - 50 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Mouton 2006 - SAD_B 100 mg - Hydroxy-Itraconazole - IV - 100 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Mouton 2006 - SAD_B 100 mg - Hydroxy-Itraconazole - IV - 100 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Mouton 2006 - SAD_A 200 mg - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Mouton 2006 - SAD_A 200 mg - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Mouton 2006 - SAD_B 300 mg - Hydroxy-Itraconazole - IV - 300 mg - Plasma - agg. (n=2)",
      "Path": "ObservedData/Mouton 2006 - SAD_B 300 mg - Hydroxy-Itraconazole - IV - 300 mg - Plasma - agg. (n=2).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_A 100 mg - Hydroxy-Itraconazole - IV - 100 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_A 100 mg - Hydroxy-Itraconazole - IV - 100 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_B 200 mg - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_B 200 mg - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_C 300 mg - Hydroxy-Itraconazole - IV - 300 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_C 300 mg - Hydroxy-Itraconazole - IV - 300 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_A 100 mg (terminal phase only) - Itraconazole - IV - 100 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_A 100 mg (terminal phase only) - Itraconazole - IV - 100 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_B 200 mg (terminal phase only) - Itraconazole - IV - 200 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_B 200 mg (terminal phase only) - Itraconazole - IV - 200 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_C 300 mg (terminal phase only) - Itraconazole - IV - 300 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_C 300 mg (terminal phase only) - Itraconazole - IV - 300 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_A 100 mg (terminal phase only) - Hydroxy-Itraconazole - IV - 100 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_A 100 mg (terminal phase only) - Hydroxy-Itraconazole - IV - 100 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_B 200 mg (terminal phase only) - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_B 200 mg (terminal phase only) - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Mouton 2006 - MAD_m_C 300 mg (terminal phase only) - Hydroxy-Itraconazole - IV - 300 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Mouton 2006 - MAD_m_C 300 mg (terminal phase only) - Hydroxy-Itraconazole - IV - 300 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Zhou 1998 - IV 200 mg OD - Itraconazole - IV - 200 mg - Plasma - agg. (n=29)",
      "Path": "ObservedData/Zhou 1998 - IV 200 mg OD - Itraconazole - IV - 200 mg - Plasma - agg. (n=29).csv"
    },
    {
      "Id": "Zhou 1998 - IV 200 mg OD - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=29)",
      "Path": "ObservedData/Zhou 1998 - IV 200 mg OD - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=29).csv"
    },
    {
      "Id": "Abdel-Rahman 2007 - 2-6y - Itraconazole - IV - 2.5 mg/kg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Abdel-Rahman 2007 - 2-6y - Itraconazole - IV - 2.5 mg_kg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Abdel-Rahman 2007 - 6-12y - Itraconazole - IV - 2.5 mg/kg - Plasma - agg. (n=7)",
      "Path": "ObservedData/Abdel-Rahman 2007 - 6-12y - Itraconazole - IV - 2.5 mg_kg - Plasma - agg. (n=7).csv"
    },
    {
      "Id": "Abdel-Rahman 2007 - 6m-2y - Itraconazole - IV - 2.5 mg/kg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Abdel-Rahman 2007 - 6m-2y - Itraconazole - IV - 2.5 mg_kg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Abdel-Rahman 2007 - 12-16y - Itraconazole - IV - 2.5 mg/kg - Plasma - agg. (n=11)",
      "Path": "ObservedData/Abdel-Rahman 2007 - 12-16y - Itraconazole - IV - 2.5 mg_kg - Plasma - agg. (n=11).csv"
    },
    {
      "Id": "Jalava 1997 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Jalava 1997 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)",
      "Path": "ObservedData/Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24).csv"
    },
    {
      "Id": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Urine - agg. (n=6)",
      "Path": "ObservedData/Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Urine - agg. (n=6).csv"
    },
    {
      "Id": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Urine - agg. (n=3)",
      "Path": "ObservedData/Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Urine - agg. (n=3).csv"
    },
    {
      "Id": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Urine - agg. (n=2)",
      "Path": "ObservedData/Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Urine - agg. (n=2).csv"
    },
    {
      "Id": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6)",
      "Path": "ObservedData/Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6).csv"
    },
    {
      "Id": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Serum - agg. (n=3)",
      "Path": "ObservedData/Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Serum - agg. (n=3).csv"
    },
    {
      "Id": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Serum - agg. (n=2)",
      "Path": "ObservedData/Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Serum - agg. (n=2).csv"
    },
    {
      "Id": "Loos 1985 - iv day 22 (Patient 4) - Rifampicin - IV/PO - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Loos 1985 - iv day 22 (Patient 4) - Rifampicin - IV_PO - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Loos 1985 - iv day 8 (Patient 4) - Rifampicin - IV/PO - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Loos 1985 - iv day 8 (Patient 4) - Rifampicin - IV_PO - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Loos 1985 - iv day 1 (Patient 4) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Loos 1985 - iv day 1 (Patient 4) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Loos 1985 - oral day 23 (Patient 4) - Rifampicin - IV/PO - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Loos 1985 - oral day 23 (Patient 4) - Rifampicin - IV_PO - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Loos 1985 - oral day 9 (Patient 4) - Rifampicin - IV/PO - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Loos 1985 - oral day 9 (Patient 4) - Rifampicin - IV_PO - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Loos 1985 - oral day 2 (Patient 4) - Rifampicin - IV/PO - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Loos 1985 - oral day 2 (Patient 4) - Rifampicin - IV_PO - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Eon Labs Manufacturing, Inc. 1997 - 2X300mg Rifadine Tab - Rifampicin - PO - 600 mg - Plasma - agg. (n=36)",
      "Path": "ObservedData/Eon Labs Manufacturing, Inc. 1997 - 2X300mg Rifadine Tab - Rifampicin - PO - 600 mg - Plasma - agg. (n=36).csv"
    },
    {
      "Id": "Eon Labs Manufacturing, Inc. 1997 - 2X300mg Tab (Eon) - Rifampicin - PO - 600 mg - Plasma - agg. (n=36)",
      "Path": "ObservedData/Eon Labs Manufacturing, Inc. 1997 - 2X300mg Tab (Eon) - Rifampicin - PO - 600 mg - Plasma - agg. (n=36).csv"
    },
    {
      "Id": "Chouchane 1995 - Rifampicin Generic - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Chouchane 1995 - Rifampicin Generic - Rifampicin - PO - 300 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Chouchane 1995 - Rimactan - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Chouchane 1995 - Rimactan - Rifampicin - PO - 300 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Burger 2006 - Rifampin alone - Rifampicin -  - 600 mg - Plasma - agg. (n=14)",
      "Path": "ObservedData/Burger 2006 - Rifampin alone - Rifampicin -  - 600 mg - Plasma - agg. (n=14).csv"
    },
    {
      "Id": "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Blume 1989 - 450 mg REFERENZ - Rifampicin - PO - 450 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Blume 1989 - 450 mg REFERENZ - Rifampicin - PO - 450 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Baneyx 2014 - Day 4 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Baneyx 2014 - Day 4 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Acocella 1984 - Individual 18 (1200 mg, 1 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 18 (1200 mg, 1 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 17 (1200 mg, 1 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 17 (1200 mg, 1 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 16 (1200 mg, 2 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 16 (1200 mg, 2 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 15 (1200 mg, 2 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 15 (1200 mg, 2 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 14 (1200 mg, 3 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 14 (1200 mg, 3 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 13 (1200 mg, 3 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 13 (1200 mg, 3 h infusion) - Rifampicin - IV - 1200 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 12 (900 mg, 1 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 12 (900 mg, 1 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 11 (900 mg, 1 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 11 (900 mg, 1 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 10 (900 mg, 2 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 10 (900 mg, 2 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 9 (900 mg, 2 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 9 (900 mg, 2 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 8 (900 mg, 3 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 8 (900 mg, 3 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 7 (900 mg, 3 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 7 (900 mg, 3 h infusion) - Rifampicin - IV - 900 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 6 (600 mg, 1 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 6 (600 mg, 1 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 5 (600 mg, 1 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 5 (600 mg, 1 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 4 (600 mg, 2 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 4 (600 mg, 2 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 3 (600 mg, 2 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 3 (600 mg, 2 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 2 (600 mg, 3 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 2 (600 mg, 3 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1984 - Individual 1 (600 mg, 3 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1984 - Individual 1 (600 mg, 3 h infusion) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Urine - agg. (n=5)",
      "Path": "ObservedData/Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Urine - agg. (n=5).csv"
    },
    {
      "Id": "Acocella 1977 - Subject 14 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 14 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 13 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 13 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 12 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 12 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 11 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 11 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 10 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 10 (600 mg MD) - Rifampicin - IV - 600 mg - Urine - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Serum - agg. (n=5)",
      "Path": "ObservedData/Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Serum - agg. (n=5).csv"
    },
    {
      "Id": "Acocella 1977 - Subject 14 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 14 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 13 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 13 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 11 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 11 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 10 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 10 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 9 (600 mg) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 9 (600 mg) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 8 (600 mg) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 8 (600 mg) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 7 (600 mg) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 7 (600 mg) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 6 (450 mg) - Rifampicin - IV - 450 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 6 (450 mg) - Rifampicin - IV - 450 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 5 (450 mg) - Rifampicin - IV - 450 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 5 (450 mg) - Rifampicin - IV - 450 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 4 (300 mg) - Rifampicin - IV - 300 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 4 (300 mg) - Rifampicin - IV - 300 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 3 (300 mg) - Rifampicin - IV - 300 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 3 (300 mg) - Rifampicin - IV - 300 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 2 (150 mg) - Rifampicin - IV - 150 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 2 (150 mg) - Rifampicin - IV - 150 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1977 - Subject 1 (150 mg) - Rifampicin - IV - 150 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 1 (150 mg) - Rifampicin - IV - 150 mg - Serum - indiv..csv"
    },
    {
      "Id": "Acocella 1972b - patients with liver disease - Rifampicin - PO - 600 mg - Urine - agg. (n=7)",
      "Path": "ObservedData/Acocella 1972b - patients with liver disease - Rifampicin - PO - 600 mg - Urine - agg. (n=7).csv"
    },
    {
      "Id": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Urine - agg. (n=6)",
      "Path": "ObservedData/Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Urine - agg. (n=6).csv"
    },
    {
      "Id": "Acocella 1972b - patients with liver disease - Rifampicin - PO - 600 mg - Serum - agg. (n=7)",
      "Path": "ObservedData/Acocella 1972b - patients with liver disease - Rifampicin - PO - 600 mg - Serum - agg. (n=7).csv"
    },
    {
      "Id": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)",
      "Path": "ObservedData/Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6).csv"
    },
    {
      "Id": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Urine - agg. (n=5)",
      "Path": "ObservedData/Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Urine - agg. (n=5).csv"
    },
    {
      "Id": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Bile - agg. (n=5)",
      "Path": "ObservedData/Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Bile - agg. (n=5).csv"
    },
    {
      "Id": "Acocella 1972a - day 7 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)",
      "Path": "ObservedData/Acocella 1972a - day 7 - Rifampicin - PO - 450 mg - Serum - agg. (n=5).csv"
    },
    {
      "Id": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)",
      "Path": "ObservedData/Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Serum - agg. (n=5).csv"
    },
    {
      "Id": "Acocella 1977 - Subject 12 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv.",
      "Path": "ObservedData/Acocella 1977 - Subject 12 (600 mg MD) - Rifampicin - IV - 600 mg - Serum - indiv..csv"
    },
    {
      "Id": "Peloquin 1999 - fast1 - Rifampicin - PO - 600 mg - Serum - agg. (n=14)",
      "Path": "ObservedData/Peloquin 1999 - fast1 - Rifampicin - PO - 600 mg - Serum - agg. (n=14).csv"
    },
    {
      "Id": "Peloquin 1999 - fast2 - Rifampicin - PO - 600 mg - Serum - agg. (n=14)",
      "Path": "ObservedData/Peloquin 1999 - fast2 - Rifampicin - PO - 600 mg - Serum - agg. (n=14).csv"
    },
    {
      "Id": "Peloquin 1999 - antacid - Rifampicin - PO - 600 mg - Serum - agg. (n=14)",
      "Path": "ObservedData/Peloquin 1999 - antacid - Rifampicin - PO - 600 mg - Serum - agg. (n=14).csv"
    },
    {
      "Id": "Peloquin 1999 - fed - Rifampicin - PO - 600 mg - Serum - agg. (n=14)",
      "Path": "ObservedData/Peloquin 1999 - fed - Rifampicin - PO - 600 mg - Serum - agg. (n=14).csv"
    },
    {
      "Id": "sanofi-aventis U.S. LLC. 2013 - 300 mg - Rifampicin - IV - 300 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/sanofi-aventis U.S. LLC. 2013 - 300 mg - Rifampicin - IV - 300 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "sanofi-aventis U.S. LLC. 2013 - 600 mg - Rifampicin - IV - 600 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/sanofi-aventis U.S. LLC. 2013 - 600 mg - Rifampicin - IV - 600 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Stone 2004 - Day 14 of Rifampin alone - Rifampicin - PO - 600 mg - Plasma - agg. (n=26)",
      "Path": "ObservedData/Stone 2004 - Day 14 of Rifampin alone - Rifampicin - PO - 600 mg - Plasma - agg. (n=26).csv"
    },
    {
      "Id": "Baneyx 2014 - Day 7 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Baneyx 2014 - Day 7 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Acocella 1985 - R alone - Rifampicin - PO - 10 mg/kg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Acocella 1985 - R alone - Rifampicin - PO - 10 mg_kg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Furesz 1970 - 100 mg - Rifampicin - PO - 100 mg - Serum - agg. (n=6)",
      "Path": "ObservedData/Furesz 1970 - 100 mg - Rifampicin - PO - 100 mg - Serum - agg. (n=6).csv"
    },
    {
      "Id": "Furesz 1970 - 150 mg - Rifampicin - PO - 150 mg - Serum - agg. (n=27)",
      "Path": "ObservedData/Furesz 1970 - 150 mg - Rifampicin - PO - 150 mg - Serum - agg. (n=27).csv"
    },
    {
      "Id": "Furesz 1970 - 250 mg - Rifampicin - PO - 250 mg - Serum - agg. (n=10)",
      "Path": "ObservedData/Furesz 1970 - 250 mg - Rifampicin - PO - 250 mg - Serum - agg. (n=10).csv"
    },
    {
      "Id": "Furesz 1970 - 300 mg - Rifampicin - PO - 300 mg - Serum - agg. (n=5)",
      "Path": "ObservedData/Furesz 1970 - 300 mg - Rifampicin - PO - 300 mg - Serum - agg. (n=5).csv"
    },
    {
      "Id": "Furesz 1970 - 450 mg - Rifampicin - PO - 450 mg - Serum - agg. (n=13)",
      "Path": "ObservedData/Furesz 1970 - 450 mg - Rifampicin - PO - 450 mg - Serum - agg. (n=13).csv"
    },
    {
      "Id": "Furesz 1970 - 600 mg - Rifampicin - PO - 600 mg - Serum - agg. (n=12)",
      "Path": "ObservedData/Furesz 1970 - 600 mg - Rifampicin - PO - 600 mg - Serum - agg. (n=12).csv"
    },
    {
      "Id": "Furesz 1970 - 750 mg - Rifampicin - PO - 750 mg - Serum - agg. (n=10)",
      "Path": "ObservedData/Furesz 1970 - 750 mg - Rifampicin - PO - 750 mg - Serum - agg. (n=10).csv"
    },
    {
      "Id": "Furesz 1970 - 900 mg - Rifampicin - PO - 900 mg - Serum - agg. (n=9)",
      "Path": "ObservedData/Furesz 1970 - 900 mg - Rifampicin - PO - 900 mg - Serum - agg. (n=9).csv"
    },
    {
      "Id": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Backman 1998 - Phase III (4 days after Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Backman 1998 - Phase III (4 days after Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Backman 1998 - Phase II (during Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Backman 1998 - Phase II (during Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Olkkola 1994 - po with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Olkkola 1994 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Olkkola 1996 - day 1 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1996 - day 1 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Olkkola 1996 - day 4 (iv) with Perpetrator (Itraconazole) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1996 - day 4 (iv) with Perpetrator (Itraconazole) - Midazolam - IV - 0.05 mg_kg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Olkkola 1996 - day 6 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1996 - day 6 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2010 - with Perpetrator (Itraconazole @ 50 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2010 - with Perpetrator (Itraconazole @ 50 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2010 - with Perpetrator (Itraconazole @ 200 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2010 - with Perpetrator (Itraconazole @ 200 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Templeton 2010 - with Perpetrator (Itraconazole @ 400 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Templeton 2010 - with Perpetrator (Itraconazole @ 400 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg_kg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Ahonen 1995 - with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Ahonen 1995 - with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
      "Path": "ObservedData/Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9).csv"
    },
    {
      "Id": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
      "Path": "ObservedData/Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg_kg - Plasma - agg. (n=18).csv"
    },
    {
      "Id": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
      "Path": "ObservedData/Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg_kg - Plasma - agg. (n=18).csv"
    },
    {
      "Id": "Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21)",
      "Path": "ObservedData/Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21).csv"
    },
    {
      "Id": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)",
      "Path": "ObservedData/Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13).csv"
    },
    {
      "Id": "Eap 2004 - 0.075 mg with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=4)",
      "Path": "ObservedData/Eap 2004 - 0.075 mg with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=4).csv"
    },
    {
      "Id": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)",
      "Path": "ObservedData/Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52).csv"
    },
    {
      "Id": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)",
      "Path": "ObservedData/Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52).csv"
    },
    {
      "Id": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
      "Path": "ObservedData/Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg_kg - Whole Blood - agg. (n=52).csv"
    },
    {
      "Id": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
      "Path": "ObservedData/Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg_kg - Whole Blood - agg. (n=52).csv"
    },
    {
      "Id": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
      "Path": "ObservedData/Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19).csv"
    },
    {
      "Id": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
      "Path": "ObservedData/Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19).csv"
    },
    {
      "Id": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
      "Path": "ObservedData/Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16).csv"
    },
    {
      "Id": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
      "Path": "ObservedData/Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9).csv"
    },
    {
      "Id": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
      "Path": "ObservedData/Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10).csv"
    },
    {
      "Id": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "Path": "ObservedData/Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12).csv"
    },
    {
      "Id": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
      "Path": "ObservedData/Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8).csv"
    },
    {
      "Id": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
      "Path": "ObservedData/Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6).csv"
    },
    {
      "Id": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
      "Path": "ObservedData/Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11).csv"
    },
    {
      "Id": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
      "Path": "ObservedData/Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11).csv"
    },
    {
      "Id": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
      "Path": "ObservedData/Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11).csv"
    },
    {
      "Id": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
      "Path": "ObservedData/Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11).csv"
    },
    {
      "Id": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
      "Path": "ObservedData/Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg_kg - Plasma - agg. (n=3).csv"
    },
    {
      "Id": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
      "Path": "ObservedData/Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg_kg - Plasma - agg. (n=3).csv"
    },
    {
      "Id": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
      "Path": "ObservedData/Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9).csv"
    },
    {
      "Id": "DDI Ratios",
      "Path": "ObservedData/DDI.csv",
      "Type": "DDIRatio"
    }
  ],
  "Plots": {
    "PlotSettings": {
      "ChartWidth": 500,
      "ChartHeight": 400,
      "Fonts": {
        "AxisSize": 11,
        "LegendSize": 9,
        "OriginSize": 9,
        "FontFamilyName": "Arial",
        "WatermarkSize": 40
      }
    },
    "AxesSettings": {
      "ComparisonTimeProfile": [
        {
          "Unit": "h",
          "Dimension": "Time",
          "Type": "X",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Unit": "g/ml",
          "Dimension": "Concentration (mass)",
          "Type": "Y",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsPredictedVsObserved": [
        {
          "Unit": "",
          "Dimension": "Dimensionless",
          "Type": "X",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Unit": "",
          "Dimension": "Dimensionless",
          "Type": "Y",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsResidualsVsObserved": [
        {
          "Unit": "",
          "Dimension": "Dimensionless",
          "Type": "X",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Unit": "",
          "Dimension": "Dimensionless",
          "Type": "Y",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "GOFMergedPlotsPredictedVsObserved": [
        {
          "Unit": "g/ml",
          "Dimension": "Concentration (mass)",
          "Type": "X",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Unit": "g/ml",
          "Dimension": "Concentration (mass)",
          "Type": "Y",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "GOFMergedPlotsResidualsOverTime": [
        {
          "Unit": "h",
          "Dimension": "Time",
          "Type": "X",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Unit": "",
          "Dimension": "Dimensionless",
          "Type": "Y",
          "GridLines": false,
          "Scaling": "Linear"
        }
      ],
      "PKRatioPlots": [
        {
          "Unit": "year(s)",
          "Dimension": "Age",
          "Type": "X",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Unit": "",
          "Dimension": "Dimensionless",
          "Type": "Y",
          "GridLines": false,
          "Scaling": "Log"
        }
      ]
    },
    "GOFMergedPlots": [
      {
        "SectionId": 14,
        "Title": "Midazolam concentration in plasma/blood",
        "PlotType": "predictedVsObserved|residualsOverTime",
        "Groups": [
          {
            "Caption": "Midazolam iv",
            "Symbol": "Circle",
            "OutputMappings": [
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.001 mg (5 min)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hohmann 2015 - iv 0.001 mg - Midazolam - IV - 0.001 mg - Plasma - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.05 mg/kg (2 min)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Olkkola 1993 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.05 mg/kg (2 min)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Saari 2006 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=10)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.05 mg/kg (2 min)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.05 mg/kg (30 min)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gorski 1998 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.05 mg/kg (30 min)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.05 mg/kg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.075 mg/kg (1 min)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Swart 2002 - day 5 Control (Perpetrator Placebo) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.075 mg/kg (1 min)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Allonen 1981 - iv - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.15 mg/kg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. A.St. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.15 mg/kg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. CH.B. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.15 mg/kg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. E.Sch. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.15 mg/kg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. K.M. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.15 mg/kg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. O.A. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 0.15 mg/kg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. R.H. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 1 mg (5 min)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hohmann 2015 - iv 1 mg - Midazolam - IV - 1 mg - Plasma - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 1 mg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 1 mg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 1 mg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 1 mg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 2 mg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 2 mg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Darwish 2008 - iv - Midazolam - IV - 2 mg - Plasma - agg. (n=24)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 5 mg (30 sec)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Schwagmeier 1998 - iv administration - Midazolam - IV - 5 mg - Plasma - agg. (n=8)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "iv 5 mg (bolus)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Smith 1981 - iv 5 mg - Midazolam - IV - 5 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Midazolam po",
            "Symbol": "Asterisk",
            "OutputMappings": [
              {
                "Project": "Midazolam",
                "Simulation": "po 0.003 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hohmann 2015 - po 0.003 mg - Midazolam - PO - 0.003 mg - Plasma - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 0.075 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 0.075 mg/kg (syrup)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 10 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 10 mg - Indiv. R.H. - Midazolam - PO - 10 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 10 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 10 mg - Indiv. O.A. - Midazolam - PO - 10 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 10 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 10 mg - Indiv. K.M. - Midazolam - PO - 10 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 10 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Smith 1981 - oral tablet 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 15 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Bornemann 1986 - fasting condition - Midazolam - PO - 15 mg - Plasma - agg. (n=18)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 15 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 15 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 15 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Olkkola 1993 - po Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 15 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Yeates 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 15 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Zimmermann 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 15 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Allonen 1981 - oral - Midazolam - PO - 15 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 2 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 20 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. R.H. - Midazolam - PO - 20 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 20 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. O.A. - Midazolam - PO - 20 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 20 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. K.M. - Midazolam - PO - 20 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 20 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. E.Sch. - Midazolam - PO - 20 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 20 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. CH.B. - Midazolam - PO - 20 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 20 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 20 mg - Indiv. A.St. - Midazolam - PO - 20 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 3 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hohmann 2015 - po 3 mg - Midazolam - PO - 3 mg - Plasma - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 3 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 3 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 4 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 4 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gorski 1998 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 40 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 40 mg - Indiv. E.Sch. - Midazolam - PO - 40 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 40 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 40 mg - Indiv. CH.B. - Midazolam - PO - 40 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 40 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heizmann 1983 - po 40 mg - Indiv. A.St. - Midazolam - PO - 40 mg - Plasma - indiv.",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 5 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Darwish 2008 - oral - Midazolam - PO - 5 mg - Plasma - agg. (n=24)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 5 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Tham 2006 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=28)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 6 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Greenblat 2003 - Control (Perpetrator Placebo) - Midazolam - PO - 6 mg - Plasma - agg. (n=25)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 7.5 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 8 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gurley 2008a - Control pre-Kava kava (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 8 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gurley 2008a - Control pre-Goldenseal (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 8 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gurley 2008a - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 8 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 8 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gurley 2006 - Control pre-Milk thistle (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 8 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gurley 2006 - Control pre-Black cohosh (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 8 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gurley 2006 - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 8 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 7.5 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 7.5 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 7.5 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 7.5 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 7.5 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Saari 2006 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=10)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 7.5 mg (tablet)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 10 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Smith 1981 - oral solution 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Midazolam",
                "Simulation": "po 2.5 mg (solution)",
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Okudaira 2007 - EM 0 Control (Perpetrator Placebo) - Midazolam - PO - 2.5 (actually 5) mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              }
            ]
          }
        ]
      },
      {
        "SectionId": 19,
        "Title": "Itraconazole concentration in plasma",
        "PlotType": "predictedVsObserved|residualsOverTime",
        "Groups": [
          {
            "Caption": "Itraconazole iv",
            "Symbol": "Cross",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "100 mg IV SD",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heykants 1989 - iv 100 mg SD - Itraconazole - IV - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "200 mg IV MD",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Itraconazole - IV - 200 mg - Plasma - agg. (n=4)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Itraconazole po solution fasted",
            "Symbol": "Circle",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Templeton 2008 - ITZ day 1 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Templeton 2008 - ITZ day 7 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg SD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Van de Velde 1996 - Fasting ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg SD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Van Peer 1989 - 100 mg Solution, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998a - day 15 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998a - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Itraconazole po solution fed",
            "Symbol": "Cross",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg SD  sol fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Van de Velde 1996 - Fed ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg SD  sol fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Heykants 1989 - po 100 mg SD fed - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD sol fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998a - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD sol fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998a - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg SD sol fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998b - Solution - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Itraconazole po capsule fasted",
            "Symbol": "Diamond",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg SD caps fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Van Peer 1989 - 100 mg Capsules, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD caps fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=9)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD caps fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Jalava 1997 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=10)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg SD caps fast",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1993 - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Itraconazole po capsule fed",
            "Symbol": "Point",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD caps fed 1",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Van Peer 1989 - 100 mg Capsules, with food, 15 days MD - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD caps fed 2",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hardin 1988 - A 100 mg OD (day 1) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD caps fed 2",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hardin 1988 - A 100 mg OD (day 7-15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD caps fed 2",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hardin 1988 - A 100 mg OD (day 15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg SD caps fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Van Peer 1989 - 100 mg Capsules, with food - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD BID caps fed 1",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1993 - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD BID caps fed 1",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1993 - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD BID caps fed 2",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hardin 1988 - C 200 mg BID (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD BID caps fed 2",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hardin 1988 - C 200 mg BID (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD BID caps fed 2",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hardin 1988 - C 200 mg BID (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD caps fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hardin 1988 - B 200 mg OD (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD caps fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hardin 1988 - B 200 mg OD (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD caps fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Hardin 1988 - B 200 mg OD (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg SD caps fed",
                "Output": "Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998b - F05 Capsule - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)",
                "Color": "#FF0000"
              }
            ]
          }
        ]
      },
      {
        "SectionId": 19,
        "Title": "Hydroxy-Itraconazole concentration in plasma",
        "PlotType": "predictedVsObserved|residualsOverTime",
        "Groups": [
          {
            "Caption": "Itraconazole iv",
            "Symbol": "Cross",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "200 mg IV MD",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Itraconazole po solution fasted",
            "Symbol": "Circle",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Templeton 2008 - OH-ITZ day 1 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Templeton 2008 - OH-ITZ day 7 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg SD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Van de Velde 1996 - Fasting OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998a - day 15 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998a - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Itraconazole po solution fed",
            "Symbol": "Cross",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg SD  sol fed",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Van de Velde 1996 - Fed OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD sol fed",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998a - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD OD sol fed",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998a - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg SD sol fed",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998b - Solution - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Itraconazole po capsule fasted",
            "Symbol": "Diamond",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg SD caps fast",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1993 - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Itraconazole po capsule fed",
            "Symbol": "Point",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD BID caps fed 1",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1993 - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg MD BID caps fed 1",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1993 - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 200 mg SD caps fed",
                "Output": "Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Barone 1998b - F05 Capsule - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)",
                "Color": "#FF0000"
              }
            ]
          }
        ]
      },
      {
        "SectionId": 19,
        "Title": "Keto-Itraconazole concentration in plasma",
        "PlotType": "predictedVsObserved|residualsOverTime",
        "Groups": [
          {
            "Caption": "Itraconazole po solution fasted",
            "Symbol": "Circle",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Keto-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Templeton 2008 - keto-ITZ day 1 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|Keto-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Templeton 2008 - keto-ITZ day 7 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              }
            ]
          }
        ]
      },
      {
        "SectionId": 19,
        "Title": "N-desalkyl-Itraconazole concentration in plasma",
        "PlotType": "predictedVsObserved|residualsOverTime",
        "Groups": [
          {
            "Caption": "Itraconazole po solution fasted",
            "Symbol": "Circle",
            "OutputMappings": [
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|N-desalkyl-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Templeton 2008 - ND-OH-ITZ day 1 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Itraconazole",
                "Simulation": "po 100 mg MD OD sol fast",
                "Output": "Organism|PeripheralVenousBlood|N-desalkyl-Itraconazole|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Templeton 2008 - ND-OH-ITZ day 7 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)",
                "Color": "#FF0000"
              }
            ]
          }
        ]
      },
      {
        "SectionId": 24,
        "Title": "Rifampicin concentration in plasma/serum",
        "PlotType": "predictedVsObserved|residualsOverTime",
        "Groups": [
          {
            "Caption": "Rifampicin iv",
            "Symbol": "Circle",
            "OutputMappings": [
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 450 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Serum - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 450 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "sanofi-aventis U.S. LLC. 2013 - 300 mg - Rifampicin - IV - 300 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 300 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Serum - agg. (n=2)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 450 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Serum - agg. (n=3)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "sanofi-aventis U.S. LLC. 2013 - 600 mg - Rifampicin - IV - 600 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              }
            ]
          },
          {
            "Caption": "Rifampicin po",
            "Symbol": "Asterisk",
            "OutputMappings": [
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 450 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 450 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Acocella 1972a - day 7 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Eon Labs Manufacturing, Inc. 1997 - 2X300mg Rifadine Tab - Rifampicin - PO - 600 mg - Plasma - agg. (n=36)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Baneyx 2014 - Day 4 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Baneyx 2014 - Day 7 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 300 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Chouchane 1995 - Rimactan - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 300 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Chouchane 1995 - Rifampicin Generic - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 300 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Furesz 1970 - 300 mg - Rifampicin - PO - 300 mg - Serum - agg. (n=5)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 450 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Blume 1989 - 450 mg REFERENZ - Rifampicin - PO - 450 mg - Plasma - agg. (n=8)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 450 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Furesz 1970 - 450 mg - Rifampicin - PO - 450 mg - Serum - agg. (n=13)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)",
                "Color": "#FF0000"
              },
              {
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg",
                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                "ObservedData": "Furesz 1970 - 600 mg - Rifampicin - PO - 600 mg - Serum - agg. (n=12)",
                "Color": "#FF0000"
              }
            ]
          }
        ]
      }
    ],
    "ComparisonTimeProfilePlots": [
      {
        "SectionId": 26,
        "Title": "Ahonen 1995",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Ahonen 1995",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Ahonen 1995 - with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 74,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 26,
        "Title": "Backman 1998",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase II (during Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9)",
            "StartTime": 74,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment Phase II (with Itraconazole)",
            "Symbol": "Square"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase III (4 days after Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9)",
            "StartTime": 170,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment Phase III (with Itraconazole)",
            "Symbol": "Triangle"
          }
        ]
      },
      {
        "SectionId": 26,
        "Title": "Olkkola 1994",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1994",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 26,
        "Title": "Olkkola 1996 (day 1 po)",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 1 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 2,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 26,
        "Title": "Olkkola 1996 (day 4 iv)",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 4 (iv) with Perpetrator (Itraconazole) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
            "StartTime": 74,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 26,
        "Title": "Olkkola 1996 (day 6 po)",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 6 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 122,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 26,
        "Title": "Templeton 2010",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Templeton 2010",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - with Perpetrator (Itraconazole @ 50 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 4,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Treatment (with 100 mg Itraconazole)",
            "Symbol": "Square"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - with Perpetrator (Itraconazole @ 200 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 4,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment (with 200 mg Itraconazole)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - with Perpetrator (Itraconazole @ 400 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 4,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 400 mg Itraconazole)",
            "Symbol": "Diamond"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Backman 1996",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
            "StartTime": 113,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Backman 1998 (Phase IV)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 113,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment Phase IV (with Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 185,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment Phase V (with Rifampicin)",
            "Symbol": "Diamond"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Chung 2006",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Chung 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
            "StartTime": 166,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Eap 2004 (0.075 mg)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 0.075 mg with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=4)",
            "StartTime": 90,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Eap 2004 (7.5 mg)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)",
            "StartTime": 114,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Gorski 2003 (iv)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gorski 2003 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Gorski 2003 (po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gorski 2003 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Gurley 2006",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gurley 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Gurley 2008",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gurley 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Kharasch 1997",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 1997",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
            "StartTime": 120,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Kharasch 2004 (iv)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
            "StartTime": 104,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Kharasch 2004 (po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2004 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
            "StartTime": 128,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Kharasch 2011 (iv, RIF @ 5 mg)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#fddbc7",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Kharasch 2011 (po, RIF @ 5 mg)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#fddbc7",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Link 2008 (iv)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Link 2008 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
            "StartTime": 144,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Link 2008 (po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Link 2008 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
            "StartTime": 144,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Phimmasone 2001",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Phimmasone 2001",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 106,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Reitman 2011",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 648,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Week 0 after treatment with rifampicin",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 816,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Week 1 after treatment with rifampicin",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 984,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Week 2 after treatment with rifampicin",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 1320,
            "TimeUnit": "h",
            "Color": "#fddbc7",
            "Caption": "Week 4 after treatment with rifampicin",
            "Symbol": "Circle"
          }
        ]
      },
      {
        "SectionId": 27,
        "Title": "Szalat 2007",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Szalat 2007",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      }
    ],
    "DDIRatioPlots": [
      {
        "SectionId": 5,
        "Title": "CYP3A4 DDI",
        "PKParameter": "AUC|CMAX",
        "PlotType": "predictedVsObserved|residualsVsObserved",
        "Groups": [
          {
            "Caption": "Itra+Mida (Mida iv)",
            "Color": "#FF0000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 378,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
                  "StartTime": 74,
                  "EndTime": 122,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Itra+Mida (Mida po)",
            "Color": "#FF0000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 50,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Ahonen 1995",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
                  "StartTime": 74,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 58,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
                  "StartTime": 74,
                  "EndTime": 170,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 59,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
                  "StartTime": 170,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 370,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1994",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
                  "StartTime": 73,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 377,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
                  "StartTime": 2,
                  "EndTime": 74,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 379,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
                  "StartTime": 122,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 424,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Templeton 2010",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
                  "StartTime": 4,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 425,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Templeton 2010",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
                  "StartTime": 4,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 426,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Templeton 2010",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
                  "StartTime": 4,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifa+Mida (Mida iv)",
            "Color": "#FF0000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 179,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gorski 2003 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 276,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 1997",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
                  "StartTime": 120,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 280,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2004 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
                  "StartTime": 104,
                  "EndTime": 128,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 294,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 295,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 296,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 297,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 342,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Link 2008 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
                  "StartTime": 144,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 389,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Phimmasone 2001",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
                  "StartTime": 106,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 422,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Szalat 2007",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifa+Mida (Mida po)",
            "Color": "#FF0000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 54,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1996",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
                  "StartTime": 113,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 56,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
                  "StartTime": 113,
                  "EndTime": 185,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 57,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
                  "StartTime": 185,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 113,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Chung 2006",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
                  "StartTime": 166,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 129,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
                  "StartTime": 90,
                  "EndTime": 114,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 132,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
                  "StartTime": 114,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 177,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gorski 2003 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 215,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gurley 2006",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
                  "StartTime": 146,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 221,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gurley 2008",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
                  "StartTime": 146,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 286,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2004 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
                  "StartTime": 128,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 304,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 305,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 306,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 307,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 344,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Link 2008 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
                  "StartTime": 144,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 392,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 1320,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 648,
                  "EndTime": 816,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 393,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 1320,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 816,
                  "EndTime": 984,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 394,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 1320,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 984,
                  "EndTime": 1320,
                  "TimeUnit": "h"
                }
              }
            ]
          }
        ]
      }
    ],
    "TimeProfile": [
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 0.001 mg (5 min)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 0.001 mg (5 min)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 0.001 mg (5 min)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Hohmann 2015 - iv 0.001 mg - Midazolam - IV - 0.001 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hohmann 2015 - iv 0.001 mg - Midazolam - IV - 0.001 mg - Plasma - agg. (n=16)|Time",
              "Y": "Hohmann 2015 - iv 0.001 mg - Midazolam - IV - 0.001 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 0.001 mg (5 min) - Plasma",
          "OriginText": "Midazolam_2.1\niv 0.001 mg (5 min)\n2018-09-28 10:55"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 0.05 mg/kg (2 min)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 0.05 mg/kg (2 min)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 0.05 mg/kg (2 min)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Saari 2006 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Saari 2006 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=10)|Time",
              "Y": "Saari 2006 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Olkkola 1993 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Olkkola 1993 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)|Time",
              "Y": "Olkkola 1993 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)|Time",
              "Y": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 0.05 mg/kg (2 min) - Plasma",
          "OriginText": "Midazolam_2.3\niv 0.05 mg/kg (2 min)\n2019-04-09 17:32"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 0.05 mg/kg (30 min)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 0.05 mg/kg (30 min)-Midazolam-Peripheral Venous Blood-Whole Blood-Concentration",
              "X": "Time",
              "Y": "iv 0.05 mg/kg (30 min)|Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 2
              }
            },
            {
              "Name": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)-Midazolam-Peripheral Venous Blood-Whole Blood-ArithmeticMean",
              "X": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|Time",
              "Y": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Gorski 1998 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)-Midazolam-Peripheral Venous Blood-Whole Blood-ArithmeticMean",
              "X": "Gorski 1998 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)|Time",
              "Y": "Gorski 1998 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 0.05 mg/kg (30 min) - Whole blood",
          "OriginText": "Midazolam-Model\niv 0.05 mg/kg (30 min)\n2019-05-09 10:32"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 0.05 mg/kg (bolus)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 0.05 mg/kg (bolus)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 0.05 mg/kg (bolus)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|Time",
              "Y": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 0.05 mg/kg (bolus) - Plasma",
          "OriginText": "Midazolam_2.2\niv 0.05 mg/kg (bolus)\n2018-10-02 13:03"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 0.075 mg/kg (1 min)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 0.075 mg/kg (1 min)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 0.075 mg/kg (1 min)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Allonen 1981 - iv - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Allonen 1981 - iv - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=6)|Time",
              "Y": "Allonen 1981 - iv - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Swart 2002 - day 5 Control (Perpetrator Placebo) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Swart 2002 - day 5 Control (Perpetrator Placebo) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)|Time",
              "Y": "Swart 2002 - day 5 Control (Perpetrator Placebo) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 0.075 mg/kg (1 min) - Plasma",
          "OriginText": "Midazolam_2.2\niv 0.075 mg/kg (1 min)\n2018-10-02 13:03"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 0.15 mg/kg (bolus)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 0.15 mg/kg (bolus)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 0.15 mg/kg (bolus)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. A.St. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. A.St. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. A.St. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. CH.B. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. CH.B. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. CH.B. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. E.Sch. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. E.Sch. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. E.Sch. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. K.M. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. K.M. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. K.M. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. O.A. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. O.A. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. O.A. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#FF8000",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. R.H. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. R.H. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - iv 0.15 mg/kg - Indiv. R.H. - Midazolam - IV - 0.15 mg/kg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#00C0C0",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 0.15 mg/kg (bolus) - Plasma",
          "OriginText": "Midazolam_2.2\niv 0.15 mg/kg (bolus)\n2018-10-02 13:04"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 1 mg (5 min)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 1 mg (5 min)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 1 mg (5 min)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Hohmann 2015 - iv 1 mg - Midazolam - IV - 1 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hohmann 2015 - iv 1 mg - Midazolam - IV - 1 mg - Plasma - agg. (n=16)|Time",
              "Y": "Hohmann 2015 - iv 1 mg - Midazolam - IV - 1 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 1 mg (5 min) - Plasma",
          "OriginText": "Midazolam_2.1\niv 1 mg (5 min)\n2018-09-28 10:55"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 1 mg (5 min)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "%",
              "Dimension": "Fraction",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0,
              "Max": 3.0,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Thummel 1996 - iv - female - Midazolam - IV - 1 mg - Urine - agg. (n=10)-Midazolam-Kidney-Urine-ArithmeticMean",
              "X": "Thummel 1996 - iv - female - Midazolam - IV - 1 mg - Urine - agg. (n=10)|Time",
              "Y": "Thummel 1996 - iv - female - Midazolam - IV - 1 mg - Urine - agg. (n=10)|ObservedData|Kidney|Urine|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Thummel 1996 - iv - male - Midazolam - IV - 1 mg - Urine - agg. (n=10)-Midazolam-Kidney-Urine-ArithmeticMean",
              "X": "Thummel 1996 - iv - male - Midazolam - IV - 1 mg - Urine - agg. (n=10)|Time",
              "Y": "Thummel 1996 - iv - male - Midazolam - IV - 1 mg - Urine - agg. (n=10)|ObservedData|Kidney|Urine|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "iv 1 mg (5 min)-Midazolam-Kidney-Urine-Fraction excreted to urine",
              "X": "Time",
              "Y": "iv 1 mg (5 min)|Organism|Kidney|Urine|Midazolam|Fraction excreted to urine",
              "CurveOptions": {
                "LegendIndex": 3
              }
            }
          ],
          "Name": "iv 1 mg (5 min) - Urine",
          "OriginText": "Midazolam-Model2\niv 1 mg (5 min)\n2019-05-10 15:26"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 1 mg (5 min)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "%",
              "Dimension": "Fraction",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 1 mg (5 min)-Midazolam-UGT1A4-Optimized Metabolite-Liver Periportal-Intracellular-Fraction of dose-Midazolam",
              "X": "Time",
              "Y": "iv 1 mg (5 min)|Organism|Liver|Periportal|Intracellular|Midazolam-UGT1A4-Optimized Metabolite|Fraction of dose-Midazolam",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Hyland 2009 - 1-mg i.v. dose (as fraction of dose) - Midazolam-N-Glucuronide - IV - 1 mg - Urine - agg. (n=6)-Midazolam-N-Glucuronide-Kidney-Urine-ArithmeticMean",
              "X": "Hyland 2009 - 1-mg i.v. dose (as fraction of dose) - Midazolam-N-Glucuronide - IV - 1 mg - Urine - agg. (n=6)|Time",
              "Y": "Hyland 2009 - 1-mg i.v. dose (as fraction of dose) - Midazolam-N-Glucuronide - IV - 1 mg - Urine - agg. (n=6)|ObservedData|Kidney|Urine|Midazolam-N-Glucuronide|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 1 mg (5 min) - fm UGT1A4",
          "OriginText": "Midazolam-Model2\niv 1 mg (5 min)\n2019-05-10 15:26"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 1 mg (bolus)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 1 mg (bolus)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 1 mg (bolus)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|Time",
              "Y": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|Time",
              "Y": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|Time",
              "Y": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 1 mg (bolus) - Plasma",
          "OriginText": "Midazolam-Model\niv 1 mg (bolus)\n2019-05-09 10:39"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 1 mg (bolus)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "%",
              "Dimension": "Fraction",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0,
              "Max": 3.0,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Thummel 1996 - iv - female - Midazolam - IV - 1 mg - Urine - agg. (n=10)-Midazolam-Kidney-Urine-ArithmeticMean",
              "X": "Thummel 1996 - iv - female - Midazolam - IV - 1 mg - Urine - agg. (n=10)|Time",
              "Y": "Thummel 1996 - iv - female - Midazolam - IV - 1 mg - Urine - agg. (n=10)|ObservedData|Kidney|Urine|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Thummel 1996 - iv - male - Midazolam - IV - 1 mg - Urine - agg. (n=10)-Midazolam-Kidney-Urine-ArithmeticMean",
              "X": "Thummel 1996 - iv - male - Midazolam - IV - 1 mg - Urine - agg. (n=10)|Time",
              "Y": "Thummel 1996 - iv - male - Midazolam - IV - 1 mg - Urine - agg. (n=10)|ObservedData|Kidney|Urine|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "iv 1 mg (bolus)-Midazolam-Kidney-Urine-Fraction excreted to urine",
              "X": "Time",
              "Y": "iv 1 mg (bolus)|Organism|Kidney|Urine|Midazolam|Fraction excreted to urine",
              "CurveOptions": {
                "LegendIndex": 1
              }
            }
          ],
          "Name": "iv 1 mg (bolus) - Urine",
          "OriginText": "Midazolam-Model\niv 1 mg (bolus)\n2019-05-09 18:41"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 1 mg (bolus)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "%",
              "Dimension": "Fraction",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 1 mg (bolus)-Midazolam-UGT1A4-Optimized Metabolite-Liver Periportal-Intracellular-Fraction of dose-Midazolam",
              "X": "Time",
              "Y": "iv 1 mg (bolus)|Organism|Liver|Periportal|Intracellular|Midazolam-UGT1A4-Optimized Metabolite|Fraction of dose-Midazolam",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Hyland 2009 - 1-mg i.v. dose (as fraction of dose) - Midazolam-N-Glucuronide - IV - 1 mg - Urine - agg. (n=6)-Midazolam-N-Glucuronide-Kidney-Urine-ArithmeticMean",
              "X": "Hyland 2009 - 1-mg i.v. dose (as fraction of dose) - Midazolam-N-Glucuronide - IV - 1 mg - Urine - agg. (n=6)|Time",
              "Y": "Hyland 2009 - 1-mg i.v. dose (as fraction of dose) - Midazolam-N-Glucuronide - IV - 1 mg - Urine - agg. (n=6)|ObservedData|Kidney|Urine|Midazolam-N-Glucuronide|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 1 mg (bolus) - fm UGT1A4",
          "OriginText": "Midazolam-Model\niv 1 mg (bolus)\n2019-05-09 18:41"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 2 mg (bolus)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 2 mg (bolus)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 2 mg (bolus)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|Time",
              "Y": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Darwish 2008 - iv - Midazolam - IV - 2 mg - Plasma - agg. (n=24)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Darwish 2008 - iv - Midazolam - IV - 2 mg - Plasma - agg. (n=24)|Time",
              "Y": "Darwish 2008 - iv - Midazolam - IV - 2 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 2 mg (bolus) - Plasma",
          "OriginText": "Midazolam_2.2\niv 2 mg (bolus)\n2018-10-02 13:10"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 5 mg (30 sec)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 5 mg (30 sec)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 5 mg (30 sec)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Schwagmeier 1998 - iv administration - Midazolam - IV - 5 mg - Plasma - agg. (n=8)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Schwagmeier 1998 - iv administration - Midazolam - IV - 5 mg - Plasma - agg. (n=8)|Time",
              "Y": "Schwagmeier 1998 - iv administration - Midazolam - IV - 5 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 5 mg (30 sec) - Plasma",
          "OriginText": "Midazolam_2.2\niv 5 mg (30 sec)\n2018-10-02 13:11"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "iv 5 mg (bolus)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "iv 5 mg (bolus)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "iv 5 mg (bolus)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Smith 1981 - iv 5 mg - Midazolam - IV - 5 mg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Smith 1981 - iv 5 mg - Midazolam - IV - 5 mg - Plasma - agg. (n=6)|Time",
              "Y": "Smith 1981 - iv 5 mg - Midazolam - IV - 5 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "iv 5 mg (bolus) - Plasma",
          "OriginText": "Midazolam_2.2\niv 5 mg (bolus)\n2018-10-02 13:12"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 0.003 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Hohmann 2015 - po 0.003 mg - Midazolam - PO - 0.003 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hohmann 2015 - po 0.003 mg - Midazolam - PO - 0.003 mg - Plasma - agg. (n=16)|Time",
              "Y": "Hohmann 2015 - po 0.003 mg - Midazolam - PO - 0.003 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "po 0.003 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 0.003 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            }
          ],
          "Name": "po 0.003 mg (solution) - Plasma",
          "OriginText": "Midazolam_2.1\npo 0.003 mg (solution)\n2018-09-28 10:55"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 0.075 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 0.075 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 0.075 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21)-Midazolam-Peripheral Venous Blood-Plasma-GeometricMean",
              "X": "Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21)|Time",
              "Y": "Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 0.075 mg (solution) - Plasma",
          "OriginText": "Midazolam_2.2\npo 0.075 mg (solution)\n2018-10-02 13:28"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 0.075 mg/kg (syrup)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 0.075 mg/kg (syrup)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 0.075 mg/kg (syrup)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 3
              }
            },
            {
              "Name": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|Time",
              "Y": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 0.075 mg/kg (syrup) - Plasma",
          "OriginText": "Midazolam_2.2\npo 0.075 mg/kg (syrup)\n2018-10-02 13:29"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 10 mg (tablet)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 10 mg (tablet)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 10 mg (tablet)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Heizmann 1983 - po 10 mg - Indiv. R.H. - Midazolam - PO - 10 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 10 mg - Indiv. R.H. - Midazolam - PO - 10 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 10 mg - Indiv. R.H. - Midazolam - PO - 10 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - po 10 mg - Indiv. O.A. - Midazolam - PO - 10 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 10 mg - Indiv. O.A. - Midazolam - PO - 10 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 10 mg - Indiv. O.A. - Midazolam - PO - 10 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - po 10 mg - Indiv. K.M. - Midazolam - PO - 10 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 10 mg - Indiv. K.M. - Midazolam - PO - 10 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 10 mg - Indiv. K.M. - Midazolam - PO - 10 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Smith 1981 - oral tablet 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Smith 1981 - oral tablet 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)|Time",
              "Y": "Smith 1981 - oral tablet 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 10 mg (tablet) - Plasma",
          "OriginText": "Midazolam_2.2\npo 10 mg (tablet)\n2018-10-02 18:35"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 15 mg (tablet)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -0.9020125,
              "Max": 25.01987,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.1672317,
              "Max": 112.8325,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 15 mg (tablet)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 15 mg (tablet)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 7
              }
            },
            {
              "Name": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|Time",
              "Y": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 9,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Yeates 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Yeates 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)|Time",
              "Y": "Yeates 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 12,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Zimmermann 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Zimmermann 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)|Time",
              "Y": "Zimmermann 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF8000",
                "LegendIndex": 13,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Allonen 1981 - oral - Midazolam - PO - 15 mg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Allonen 1981 - oral - Midazolam - PO - 15 mg - Plasma - agg. (n=6)|Time",
              "Y": "Allonen 1981 - oral - Midazolam - PO - 15 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#00C0C0",
                "LegendIndex": 14,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|Time",
              "Y": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 8,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Olkkola 1993 - po Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Olkkola 1993 - po Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)|Time",
              "Y": "Olkkola 1993 - po Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 11,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Bornemann 1986 - fasting condition - Midazolam - PO - 15 mg - Plasma - agg. (n=18)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Bornemann 1986 - fasting condition - Midazolam - PO - 15 mg - Plasma - agg. (n=18)|Time",
              "Y": "Bornemann 1986 - fasting condition - Midazolam - PO - 15 mg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#C000C0",
                "LegendIndex": 15,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 15 mg (tablet) - Plasma",
          "OriginText": "Midazolam_2.2\npo 15 mg (tablet)\n2018-10-02 18:23"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 2 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 2 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 2 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)|Time",
              "Y": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 2 mg (solution) - Plasma",
          "OriginText": "Midazolam_2.2\npo 2 mg (solution)\n2018-10-02 18:35"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 20 mg (tablet)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 20 mg (tablet)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 20 mg (tablet)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Heizmann 1983 - po 20 mg - Indiv. R.H. - Midazolam - PO - 20 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 20 mg - Indiv. R.H. - Midazolam - PO - 20 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 20 mg - Indiv. R.H. - Midazolam - PO - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - po 20 mg - Indiv. O.A. - Midazolam - PO - 20 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 20 mg - Indiv. O.A. - Midazolam - PO - 20 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 20 mg - Indiv. O.A. - Midazolam - PO - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - po 20 mg - Indiv. K.M. - Midazolam - PO - 20 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 20 mg - Indiv. K.M. - Midazolam - PO - 20 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 20 mg - Indiv. K.M. - Midazolam - PO - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - po 20 mg - Indiv. E.Sch. - Midazolam - PO - 20 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 20 mg - Indiv. E.Sch. - Midazolam - PO - 20 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 20 mg - Indiv. E.Sch. - Midazolam - PO - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - po 20 mg - Indiv. CH.B. - Midazolam - PO - 20 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 20 mg - Indiv. CH.B. - Midazolam - PO - 20 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 20 mg - Indiv. CH.B. - Midazolam - PO - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#FF8000",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - po 20 mg - Indiv. A.St. - Midazolam - PO - 20 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 20 mg - Indiv. A.St. - Midazolam - PO - 20 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 20 mg - Indiv. A.St. - Midazolam - PO - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#00C0C0",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 20 mg (tablet) - Plasma",
          "OriginText": "Midazolam_2.2\npo 20 mg (tablet)\n2018-10-02 18:37"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 3 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|Time",
              "Y": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Hohmann 2015 - po 3 mg - Midazolam - PO - 3 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hohmann 2015 - po 3 mg - Midazolam - PO - 3 mg - Plasma - agg. (n=16)|Time",
              "Y": "Hohmann 2015 - po 3 mg - Midazolam - PO - 3 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "po 3 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 3 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            }
          ],
          "Name": "po 3 mg (solution) - Plasma",
          "OriginText": "Midazolam_2.3c\npo 3 mg (solution)\n2019-04-11 18:13"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 3 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "%",
              "Dimension": "Fraction",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 1.017808E-05,
              "Max": 3.0,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Thummel 1996 - po - male - Midazolam - PO - 2 mg - Urine - agg. (n=10)-Midazolam-Kidney-Urine-ArithmeticMean",
              "X": "Thummel 1996 - po - male - Midazolam - PO - 2 mg - Urine - agg. (n=10)|Time",
              "Y": "Thummel 1996 - po - male - Midazolam - PO - 2 mg - Urine - agg. (n=10)|ObservedData|Kidney|Urine|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Thummel 1996 - po - female - Midazolam - PO - 2 mg - Urine - agg. (n=10)-Midazolam-Kidney-Urine-ArithmeticMean",
              "X": "Thummel 1996 - po - female - Midazolam - PO - 2 mg - Urine - agg. (n=10)|Time",
              "Y": "Thummel 1996 - po - female - Midazolam - PO - 2 mg - Urine - agg. (n=10)|ObservedData|Kidney|Urine|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "po 3 mg (solution)-Midazolam-Kidney-Urine-Fraction excreted to urine",
              "X": "Time",
              "Y": "po 3 mg (solution)|Organism|Kidney|Urine|Midazolam|Fraction excreted to urine",
              "CurveOptions": {
                "LegendIndex": 1
              }
            }
          ],
          "Name": "po 3 mg (solution) - Urine",
          "OriginText": "Midazolam-Model2\npo 3 mg (solution)\n2019-05-10 15:28"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 3 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "%",
              "Dimension": "Fraction",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Hyland 2009 - 3-mg oral dose (as fraction of dose) - Midazolam-N-Glucuronide - PO - 3 mg - Urine - agg. (n=6)-Midazolam-N-Glucuronide-Kidney-Urine-ArithmeticMean",
              "X": "Hyland 2009 - 3-mg oral dose (as fraction of dose) - Midazolam-N-Glucuronide - PO - 3 mg - Urine - agg. (n=6)|Time",
              "Y": "Hyland 2009 - 3-mg oral dose (as fraction of dose) - Midazolam-N-Glucuronide - PO - 3 mg - Urine - agg. (n=6)|ObservedData|Kidney|Urine|Midazolam-N-Glucuronide|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "po 3 mg (solution)-Midazolam-UGT1A4-Optimized Metabolite-Liver Periportal-Intracellular-Fraction of dose-Midazolam",
              "X": "Time",
              "Y": "po 3 mg (solution)|Organism|Liver|Periportal|Intracellular|Midazolam-UGT1A4-Optimized Metabolite|Fraction of dose-Midazolam",
              "CurveOptions": {
                "LegendIndex": 1
              }
            }
          ],
          "Name": "po 3 mg (solution) - fm UGT1A4",
          "OriginText": "Midazolam-Model2\npo 3 mg (solution)\n2019-05-10 15:28"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 4 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 4 mg (solution)-Midazolam-Peripheral Venous Blood-Whole Blood-Concentration",
              "X": "Time",
              "Y": "po 4 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 2
              }
            },
            {
              "Name": "Gorski 1998 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16)-Midazolam-Peripheral Venous Blood-Whole Blood-ArithmeticMean",
              "X": "Gorski 1998 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16)|Time",
              "Y": "Gorski 1998 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)-Midazolam-Peripheral Venous Blood-Whole Blood-ArithmeticMean",
              "X": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)|Time",
              "Y": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 4 mg (solution) - Whole blood",
          "OriginText": "Midazolam_2.2\npo 4 mg (solution)\n2018-10-02 18:37"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 40 mg (tablet)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 40 mg (tablet)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 40 mg (tablet)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Heizmann 1983 - po 40 mg - Indiv. A.St. - Midazolam - PO - 40 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 40 mg - Indiv. A.St. - Midazolam - PO - 40 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 40 mg - Indiv. A.St. - Midazolam - PO - 40 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - po 40 mg - Indiv. CH.B. - Midazolam - PO - 40 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 40 mg - Indiv. CH.B. - Midazolam - PO - 40 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 40 mg - Indiv. CH.B. - Midazolam - PO - 40 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heizmann 1983 - po 40 mg - Indiv. E.Sch. - Midazolam - PO - 40 mg - Plasma - indiv.-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Heizmann 1983 - po 40 mg - Indiv. E.Sch. - Midazolam - PO - 40 mg - Plasma - indiv.|Time",
              "Y": "Heizmann 1983 - po 40 mg - Indiv. E.Sch. - Midazolam - PO - 40 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 40 mg (tablet) - Plasma",
          "OriginText": "Midazolam_2.2\npo 40 mg (tablet)\n2018-10-02 18:38"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 5 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 5 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 5 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Tham 2006 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=28)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Tham 2006 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=28)|Time",
              "Y": "Tham 2006 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 9,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Darwish 2008 - oral - Midazolam - PO - 5 mg - Plasma - agg. (n=24)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Darwish 2008 - oral - Midazolam - PO - 5 mg - Plasma - agg. (n=24)|Time",
              "Y": "Darwish 2008 - oral - Midazolam - PO - 5 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 8,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 5 mg (solution) - Plasma",
          "OriginText": "Midazolam_2.2\npo 5 mg (solution)\n2018-10-02 18:18"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 6 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 6 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 6 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 3
              }
            },
            {
              "Name": "Greenblat 2003 - Control (Perpetrator Placebo) - Midazolam - PO - 6 mg - Plasma - agg. (n=25)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Greenblat 2003 - Control (Perpetrator Placebo) - Midazolam - PO - 6 mg - Plasma - agg. (n=25)|Time",
              "Y": "Greenblat 2003 - Control (Perpetrator Placebo) - Midazolam - PO - 6 mg - Plasma - agg. (n=25)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 6 mg (solution) - Plasma",
          "OriginText": "Midazolam_2.2\npo 6 mg (solution)\n2018-10-02 18:39"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 7.5 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 7.5 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 7.5 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)-Midazolam-Peripheral Venous Blood-Plasma-GeometricMean",
              "X": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)|Time",
              "Y": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 7.5 mg (solution) - Plasma",
          "OriginText": "Midazolam_2.2\npo 7.5 mg (solution)\n2018-10-02 18:39"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 8 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 8 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 8 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Gurley 2008a - Control pre-Kava kava (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2008a - Control pre-Kava kava (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|Time",
              "Y": "Gurley 2008a - Control pre-Kava kava (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#C04000",
                "LegendIndex": 9,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Gurley 2008a - Control pre-Goldenseal (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2008a - Control pre-Goldenseal (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|Time",
              "Y": "Gurley 2008a - Control pre-Goldenseal (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#C000C0",
                "LegendIndex": 8,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Gurley 2008a - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2008a - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|Time",
              "Y": "Gurley 2008a - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#00C0C0",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|Time",
              "Y": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF8000",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Gurley 2006 - Control pre-Milk thistle (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2006 - Control pre-Milk thistle (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|Time",
              "Y": "Gurley 2006 - Control pre-Milk thistle (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Gurley 2006 - Control pre-Black cohosh (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2006 - Control pre-Black cohosh (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|Time",
              "Y": "Gurley 2006 - Control pre-Black cohosh (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Gurley 2006 - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2006 - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|Time",
              "Y": "Gurley 2006 - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|Time",
              "Y": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 8 mg (solution) - Plasma",
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "Bottom",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Midazolam_2.2\npo 8 mg (solution)\n2018-10-09 15:06"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 7.5 mg (tablet)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -0.2275229,
              "Max": 25.26728,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.09416887,
              "Max": 336.4494,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 7.5 mg (tablet)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 7.5 mg (tablet)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Saari 2006 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Saari 2006 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=10)|Time",
              "Y": "Saari 2006 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#00C0C0",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)|Time",
              "Y": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF8000",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)|Time",
              "Y": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)|Time",
              "Y": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|Time",
              "Y": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)|Time",
              "Y": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 7.5 mg (tablet) - Plasma",
          "OriginText": "Midazolam-Model\npo 7.5 mg (tablet)\n2019-05-10 09:26"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 10 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 10 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 10 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Smith 1981 - oral solution 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Smith 1981 - oral solution 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)|Time",
              "Y": "Smith 1981 - oral solution 10 mg - Midazolam - PO - 10 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 10 mg (solution) - Plasma",
          "OriginText": "Midazolam_2.2\npo 10 mg (solution)\n2018-10-02 18:50"
        }
      },
      {
        "SectionId": 13,
        "Project": "Midazolam",
        "Simulation": "po 2.5 mg (solution)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 2.5 mg (solution)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 2.5 mg (solution)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Okudaira 2007 - EM 0 Control (Perpetrator Placebo) - Midazolam - PO - 2.5 (actually 5) mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Okudaira 2007 - EM 0 Control (Perpetrator Placebo) - Midazolam - PO - 2.5 (actually 5) mg - Plasma - agg. (n=12)|Time",
              "Y": "Okudaira 2007 - EM 0 Control (Perpetrator Placebo) - Midazolam - PO - 2.5 (actually 5) mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 2.5 mg (solution) - Plasma",
          "OriginText": "Midazolam-Model\npo 2.5 mg (solution)\n2019-05-09 18:32"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "100 mg IV SD",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "100 mg IV SD-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "100 mg IV SD|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 3
              }
            },
            {
              "Name": "Heykants 1989 - iv 100 mg SD - Itraconazole - IV - 100 mg - Plasma - agg. (n=6)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Heykants 1989 - iv 100 mg SD - Itraconazole - IV - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Heykants 1989 - iv 100 mg SD - Itraconazole - IV - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "100 mg IV SD - Plasma",
          "OriginText": "Itraconazole-Model\n100 mg IV SD\n2019-04-12 16:17"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "200 mg IV MD",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -11.80577,
              "Max": 326.0029,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 104.1166,
              "Max": 5095.684,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "200 mg IV MD-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "200 mg IV MD|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "200 mg IV MD-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "200 mg IV MD|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4)|Time",
              "Y": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Hydroxy-Itraconazole - IV - 200 mg - Plasma - agg. (n=4)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Itraconazole - IV - 200 mg - Plasma - agg. (n=4)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Itraconazole - IV - 200 mg - Plasma - agg. (n=4)|Time",
              "Y": "Mouton 2006 - MAD_m_D 200 mg (HPBCD) - Itraconazole - IV - 200 mg - Plasma - agg. (n=4)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "200 mg IV MD - Plasma",
          "OriginText": "Itraconazole-Model\n200 mg IV MD\n2019-04-12 16:40"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 100 mg SD caps fast",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -2.569952,
              "Max": 101.485,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.2445602,
              "Max": 106.0987,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 100 mg SD caps fast-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg SD caps fast|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 2
              }
            },
            {
              "Name": "Van Peer 1989 - 100 mg Capsules, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Van Peer 1989 - 100 mg Capsules, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Van Peer 1989 - 100 mg Capsules, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 100 mg SD caps fast - Plasma",
          "OriginText": "Itraconazole-Model\npo 100 mg SD caps fast\n2019-05-08 17:51"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 200 mg MD OD caps fast",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -3.040238,
              "Max": 123.9491,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 27.75721,
              "Max": 879.8425,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=9)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=9)|Time",
              "Y": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "po 200 mg MD OD caps fast-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg MD OD caps fast|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 2
              }
            },
            {
              "Name": "Jalava 1997 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=10)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Jalava 1997 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=10)|Time",
              "Y": "Jalava 1997 - po with Perpetrator (Itraconazole) - Itraconazole - PO - 200 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 200 mg MD OD caps fast - Plasma",
          "OriginText": "Itraconazole-Model\npo 200 mg MD OD caps fast\n2019-05-14 18:01"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 200 mg SD caps fast",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -2.175233,
              "Max": 81.63765,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.4256021,
              "Max": 445.8362,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 200 mg SD caps fast-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg SD caps fast|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "po 200 mg SD caps fast-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg SD caps fast|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Barone 1993 - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1993 - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|Time",
              "Y": "Barone 1993 - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1993 - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1993 - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|Time",
              "Y": "Barone 1993 - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 200 mg SD caps fast - Plasma",
          "OriginText": "Itraconazole-Model\npo 200 mg SD caps fast\n2019-04-15 13:48"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 100 mg MD OD caps fed 1",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -4.807096,
              "Max": 436.3823,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 10.91725,
              "Max": 533.1278,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 100 mg MD OD caps fed 1-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg MD OD caps fed 1|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 2
              }
            },
            {
              "Name": "Van Peer 1989 - 100 mg Capsules, with food, 15 days MD - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Van Peer 1989 - 100 mg Capsules, with food, 15 days MD - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Van Peer 1989 - 100 mg Capsules, with food, 15 days MD - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 100 mg MD OD caps fed 1 - Plasma",
          "OriginText": "Itraconazole-Model\npo 100 mg QD (vanPeer 89) caps fed\n2019-04-15 14:00"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 100 mg MD OD caps fed 2",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -21.6675,
              "Max": 438.4218,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 4.222414,
              "Max": 393.355,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 100 mg MD OD caps fed 2-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg MD OD caps fed 2|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 2
              }
            },
            {
              "Name": "Hardin 1988 - A 100 mg OD (day 7-15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hardin 1988 - A 100 mg OD (day 7-15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)|Time",
              "Y": "Hardin 1988 - A 100 mg OD (day 7-15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Hardin 1988 - A 100 mg OD (day 1) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hardin 1988 - A 100 mg OD (day 1) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)|Time",
              "Y": "Hardin 1988 - A 100 mg OD (day 1) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Hardin 1988 - A 100 mg OD (day 15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hardin 1988 - A 100 mg OD (day 15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)|Time",
              "Y": "Hardin 1988 - A 100 mg OD (day 15) - Itraconazole - PO - 100 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 100 mg MD OD caps fed 2 - Plasma",
          "OriginText": "Itraconazole-Model\npo 100 mg QD (Hardin 88) caps fed\n2019-04-15 13:46"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 100 mg SD caps fed",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -3.148333,
              "Max": 102.0413,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.2940407,
              "Max": 295.5439,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 100 mg SD caps fed-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg SD caps fed|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Van Peer 1989 - 100 mg Capsules, with food - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Van Peer 1989 - 100 mg Capsules, with food - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Van Peer 1989 - 100 mg Capsules, with food - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 100 mg SD caps fed - Plasma",
          "OriginText": "Itraconazole-Model\npo 100 mg SD caps fed\n2019-04-15 14:03"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 200 mg MD BID caps fed 1",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -28.10532,
              "Max": 823.8434,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 2.228176,
              "Max": 19436.38,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 200 mg MD BID caps fed 1-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg MD BID caps fed 1|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "po 200 mg MD BID caps fed 1-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg MD BID caps fed 1|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Barone 1993 - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1993 - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|Time",
              "Y": "Barone 1993 - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1993 - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1993 - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|Time",
              "Y": "Barone 1993 - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1993 - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1993 - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|Time",
              "Y": "Barone 1993 - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1993 - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1993 - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|Time",
              "Y": "Barone 1993 - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 200 mg MD BID caps fed 1 - Plasma",
          "OriginText": "Itraconazole-Model\npo 200 mg MD BID caps fed\n2019-04-15 14:08"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 200 mg MD BID caps fed 2",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -16.34613,
              "Max": 437.2916,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 22.0896,
              "Max": 2777.658,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Hardin 1988 - C 200 mg BID (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hardin 1988 - C 200 mg BID (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|Time",
              "Y": "Hardin 1988 - C 200 mg BID (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "po 200 mg MD BID caps fed 2-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg MD BID caps fed 2|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 2
              }
            },
            {
              "Name": "Hardin 1988 - C 200 mg BID (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hardin 1988 - C 200 mg BID (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|Time",
              "Y": "Hardin 1988 - C 200 mg BID (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Hardin 1988 - C 200 mg BID (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hardin 1988 - C 200 mg BID (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|Time",
              "Y": "Hardin 1988 - C 200 mg BID (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 200 mg MD BID caps fed 2 - Plasma",
          "OriginText": "Itraconazole-Model\npo 200 mg BID (Hardin 88) caps fed\n2019-04-15 14:13"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 200 mg MD OD caps fed",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -9.18835,
              "Max": 439.67,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 5.685065,
              "Max": 1587.896,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Hardin 1988 - B 200 mg OD (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hardin 1988 - B 200 mg OD (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|Time",
              "Y": "Hardin 1988 - B 200 mg OD (day 1) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "po 200 mg MD OD caps fed-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg MD OD caps fed|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 2
              }
            },
            {
              "Name": "Hardin 1988 - B 200 mg OD (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hardin 1988 - B 200 mg OD (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|Time",
              "Y": "Hardin 1988 - B 200 mg OD (day 15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Hardin 1988 - B 200 mg OD (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Hardin 1988 - B 200 mg OD (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|Time",
              "Y": "Hardin 1988 - B 200 mg OD (day 7-15) - Itraconazole - PO - 200 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 200 mg MD OD caps fed - Plasma",
          "OriginText": "Itraconazole-Model\npo 200 mg MD OD caps fed\n2019-04-15 14:18"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 200 mg SD caps fed",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -5.08,
              "Max": 106.475,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.8380451,
              "Max": 1245.367,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 200 mg SD caps fed-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg SD caps fed|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3
              }
            },
            {
              "Name": "po 200 mg SD caps fed-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg SD caps fed|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Barone 1993 - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1993 - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|Time",
              "Y": "Barone 1993 - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#95B3D7",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1993 - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1993 - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|Time",
              "Y": "Barone 1993 - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#D99694",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1998b - F05 Capsule - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998b - F05 Capsule - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)|Time",
              "Y": "Barone 1998b - F05 Capsule - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#953734",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1998b - F05 Capsule - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998b - F05 Capsule - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)|Time",
              "Y": "Barone 1998b - F05 Capsule - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#366092",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 200 mg SD caps fed - Plasma",
          "OriginText": "Itraconazole-Model\npo 200 mg SD caps fed\n2019-04-15 14:20"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 100 mg MD OD sol fast",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.1,
              "Max": 10000.0,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 100 mg MD OD sol fast-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg MD OD sol fast|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "po 100 mg MD OD sol fast-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg MD OD sol fast|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "po 100 mg MD OD sol fast-Keto-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg MD OD sol fast|Organism|PeripheralVenousBlood|Keto-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4
              }
            },
            {
              "Name": "po 100 mg MD OD sol fast-N-desalkyl-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg MD OD sol fast|Organism|PeripheralVenousBlood|N-desalkyl-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 5
              }
            },
            {
              "Name": "Templeton 2008 - ITZ day 1 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Templeton 2008 - ITZ day 1 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Templeton 2008 - ITZ day 1 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Templeton 2008 - ITZ day 7 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Templeton 2008 - ITZ day 7 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Templeton 2008 - ITZ day 7 - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Templeton 2008 - keto-ITZ day 1 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Keto-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Templeton 2008 - keto-ITZ day 1 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Templeton 2008 - keto-ITZ day 1 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Keto-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 8,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Templeton 2008 - keto-ITZ day 7 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Keto-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Templeton 2008 - keto-ITZ day 7 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Templeton 2008 - keto-ITZ day 7 - Keto-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Keto-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 9,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Templeton 2008 - ND-OH-ITZ day 1 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-N-desalkyl-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Templeton 2008 - ND-OH-ITZ day 1 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Templeton 2008 - ND-OH-ITZ day 1 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|N-desalkyl-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 10,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Templeton 2008 - ND-OH-ITZ day 7 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-N-desalkyl-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Templeton 2008 - ND-OH-ITZ day 7 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Templeton 2008 - ND-OH-ITZ day 7 - N-desalkyl-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|N-desalkyl-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 11,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Templeton 2008 - OH-ITZ day 1 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Templeton 2008 - OH-ITZ day 1 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Templeton 2008 - OH-ITZ day 1 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 12,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Templeton 2008 - OH-ITZ day 7 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Templeton 2008 - OH-ITZ day 7 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Templeton 2008 - OH-ITZ day 7 - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 13,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 100 mg MD OD sol fast - Plasma",
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Itraconazole-Model\npo 100 mg QD (Templeton 08) sol fast\n2019-04-15 14:30"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 100 mg SD sol fast",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -1.596248,
              "Max": 100.8333,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.5348182,
              "Max": 544.6929,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 100 mg SD sol fast-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg SD sol fast|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "po 100 mg SD sol fast-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg SD sol fast|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Van de Velde 1996 - Fasting OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Van de Velde 1996 - Fasting OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)|Time",
              "Y": "Van de Velde 1996 - Fasting OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#95B3D7",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Van de Velde 1996 - Fasting ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Van de Velde 1996 - Fasting ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)|Time",
              "Y": "Van de Velde 1996 - Fasting ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#D99694",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Van Peer 1989 - 100 mg Solution, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Van Peer 1989 - 100 mg Solution, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Van Peer 1989 - 100 mg Solution, fasting - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#953734",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 100 mg SD sol fast - Plasma",
          "OriginText": "Itraconazole-Model\npo 100 mg SD (vanDeVelde 96) sol fast\n2019-04-15 14:37"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 200 mg MD OD sol fast",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -15.02064,
              "Max": 386.7004,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 39.60292,
              "Max": 2708.294,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 200 mg MD OD sol fast-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg MD OD sol fast|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "po 200 mg MD OD sol fast-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg MD OD sol fast|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Barone 1998a - day 15 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998a - day 15 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|Time",
              "Y": "Barone 1998a - day 15 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1998a - day 15 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998a - day 15 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|Time",
              "Y": "Barone 1998a - day 15 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 8,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1998a - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998a - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|Time",
              "Y": "Barone 1998a - day 1 fasted - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 9,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1998a - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998a - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|Time",
              "Y": "Barone 1998a - day 1 fasted - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 10,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 200 mg MD OD sol fast - Plasma",
          "OriginText": "Itraconazole-Model\npo 200 mg QD (Barone 1998a) sol fast\n2019-04-15 14:34"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 100 mg SD  sol fed",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -1.46328,
              "Max": 102.4734,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 2.927261,
              "Max": 435.527,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 100 mg SD  sol fed-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg SD  sol fed|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "po 100 mg SD  sol fed-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 100 mg SD  sol fed|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Van de Velde 1996 - Fed OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Van de Velde 1996 - Fed OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)|Time",
              "Y": "Van de Velde 1996 - Fed OH-ITZ - Hydroxy-Itraconazole - PO - 100 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#95B3D7",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Van de Velde 1996 - Fed ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Van de Velde 1996 - Fed ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)|Time",
              "Y": "Van de Velde 1996 - Fed ITZ - Itraconazole - PO - 100 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#D99694",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Heykants 1989 - po 100 mg SD fed - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Heykants 1989 - po 100 mg SD fed - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|Time",
              "Y": "Heykants 1989 - po 100 mg SD fed - Itraconazole - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#953734",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 100 mg SD  sol fed - Plasma",
          "OriginText": "Itraconazole-Model\npo 100 mg SD (vanDeVelde 96) sol fed\n2019-04-15 14:39"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 200 mg MD OD sol fed",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -20.90228,
              "Max": 371.375,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 103.0857,
              "Max": 3039.307,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 200 mg MD OD sol fed-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg MD OD sol fed|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "po 200 mg MD OD sol fed-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg MD OD sol fed|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Barone 1998a - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998a - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|Time",
              "Y": "Barone 1998a - day 1 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1998a - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998a - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|Time",
              "Y": "Barone 1998a - day 1 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1998a - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998a - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|Time",
              "Y": "Barone 1998a - day 15 fed - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1998a - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998a - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|Time",
              "Y": "Barone 1998a - day 15 fed - Itraconazole - PO - 200 mg - Plasma - agg. (n=27)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 200 mg MD OD sol fed - Plasma",
          "OriginText": "Itraconazole-Model\npo 200 mg QD (Barone 98a) sol fed\n2019-04-15 14:41"
        }
      },
      {
        "SectionId": 18,
        "Project": "Itraconazole",
        "Simulation": "po 200 mg SD sol fed",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -0.8922527,
              "Max": 103.9611,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.9404082,
              "Max": 703.5985,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "po 200 mg SD sol fed-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg SD sol fed|Organism|PeripheralVenousBlood|Hydroxy-Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "po 200 mg SD sol fed-Itraconazole-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "po 200 mg SD sol fed|Organism|PeripheralVenousBlood|Itraconazole|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Barone 1998b - Solution - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)-Hydroxy-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998b - Solution - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)|Time",
              "Y": "Barone 1998b - Solution - Hydroxy-Itraconazole - PO - 200 mg - Plasma - agg. (n=30)|ObservedData|Peripheral Venous Blood|Plasma|Hydroxy-Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Barone 1998b - Solution - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)-Itraconazole-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Barone 1998b - Solution - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)|Time",
              "Y": "Barone 1998b - Solution - Itraconazole - PO - 200 mg - Plasma - agg. (n=30)|ObservedData|Peripheral Venous Blood|Plasma|Itraconazole|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "po 200 mg SD sol fed - Plasma",
          "OriginText": "Itraconazole-Model\npo 200 mg SD sol fed\n2019-04-15 14:43"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin iv 600 mg (3 h) MD OD (7 days)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin iv 600 mg (3 h) MD OD (7 days)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin iv 600 mg (3 h) MD OD (7 days)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Serum - agg. (n=5)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Serum - agg. (n=5)|Time",
              "Y": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Serum - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6)|Time",
              "Y": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin iv 600 mg (3 h) MD OD (7 days) - Plasma",
          "OriginText": "Rifampicin-Model2\nRifampicin iv 600 mg (3 h) MD OD (7 days)\n2019-05-13 13:18"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin iv 300 mg (0.5 h)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin iv 300 mg (0.5 h)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin iv 300 mg (0.5 h)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "sanofi-aventis U.S. LLC. 2013 - 300 mg - Rifampicin - IV - 300 mg - Plasma - agg. (n=12)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "sanofi-aventis U.S. LLC. 2013 - 300 mg - Rifampicin - IV - 300 mg - Plasma - agg. (n=12)|Time",
              "Y": "sanofi-aventis U.S. LLC. 2013 - 300 mg - Rifampicin - IV - 300 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin iv 300 mg (0.5 h) - Plasma"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin iv 300 mg (3 h)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin iv 300 mg (3 h)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin iv 300 mg (3 h)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Serum - agg. (n=2)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Serum - agg. (n=2)|Time",
              "Y": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Serum - agg. (n=2)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin iv 300 mg (3 h) - Plasma",
          "OriginText": "Rifampicin-Model2\nRifampicin iv 300 mg (3 h)\n2019-05-13 13:27"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin iv 300 mg (3 h)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "mg",
              "Dimension": "Amount",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin iv 300 mg (3 h)-Rifampicin-Kidney-Urine-Amount in container",
              "X": "Time",
              "Y": "Rifampicin iv 300 mg (3 h)|Organism|Kidney|Urine|Rifampicin",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Urine - agg. (n=2)-Rifampicin-Kidney-Urine-ArithmeticMean",
              "X": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Urine - agg. (n=2)|Time",
              "Y": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Urine - agg. (n=2)|ObservedData|Kidney|Urine|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin iv 300 mg (3 h) - Urine",
          "OriginText": "Rifampicin-Model2\nRifampicin iv 300 mg (3 h)\n2019-05-13 13:27"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin iv 450 mg (3 h)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin iv 450 mg (3 h)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin iv 450 mg (3 h)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Serum - agg. (n=3)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Serum - agg. (n=3)|Time",
              "Y": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Serum - agg. (n=3)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin iv 450 mg (3 h) - Plasma",
          "OriginText": "Rifampicin-Model2\nRifampicin iv 450 mg (3 h)\n2019-05-13 13:25"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin iv 450 mg (3 h)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "mg",
              "Dimension": "Amount",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin iv 450 mg (3 h)-Rifampicin-Kidney-Urine-Amount in container",
              "X": "Time",
              "Y": "Rifampicin iv 450 mg (3 h)|Organism|Kidney|Urine|Rifampicin",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Urine - agg. (n=3)-Rifampicin-Kidney-Urine-ArithmeticMean",
              "X": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Urine - agg. (n=3)|Time",
              "Y": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Urine - agg. (n=3)|ObservedData|Kidney|Urine|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin iv 450 mg (3 h) - Urine",
          "OriginText": "Rifampicin-Model2\nRifampicin iv 450 mg (3 h)\n2019-05-13 13:25"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin iv 600 mg (0.5 h)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin iv 600 mg (0.5 h)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin iv 600 mg (0.5 h)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "sanofi-aventis U.S. LLC. 2013 - 600 mg - Rifampicin - IV - 600 mg - Plasma - agg. (n=12)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "sanofi-aventis U.S. LLC. 2013 - 600 mg - Rifampicin - IV - 600 mg - Plasma - agg. (n=12)|Time",
              "Y": "sanofi-aventis U.S. LLC. 2013 - 600 mg - Rifampicin - IV - 600 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin iv 600 mg (0.5 h) - Plasma"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin iv 600 mg (3 h)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin iv 600 mg (3 h)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin iv 600 mg (3 h)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6)|Time",
              "Y": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin iv 600 mg (3 h) - Plasma",
          "OriginText": "Rifampicin-Model2\nRifampicin iv 600 mg (3 h)\n2019-05-13 13:22"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin iv 600 mg (3 h)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "mg",
              "Dimension": "Amount",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin iv 600 mg (3 h)-Rifampicin-Kidney-Urine-Amount in container",
              "X": "Time",
              "Y": "Rifampicin iv 600 mg (3 h)|Organism|Kidney|Urine|Rifampicin",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Urine - agg. (n=5)-Rifampicin-Kidney-Urine-ArithmeticMean",
              "X": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Urine - agg. (n=5)|Time",
              "Y": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Urine - agg. (n=5)|ObservedData|Kidney|Urine|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Urine - agg. (n=6)-Rifampicin-Kidney-Urine-ArithmeticMean",
              "X": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Urine - agg. (n=6)|Time",
              "Y": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Urine - agg. (n=6)|ObservedData|Kidney|Urine|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin iv 600 mg (3 h) - Urine",
          "OriginText": "Rifampicin-Model2\nRifampicin iv 600 mg (3 h)\n2019-05-13 13:22"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin po 450 mg MD OD (7 days)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin po 450 mg MD OD (7 days)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin po 450 mg MD OD (7 days)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)|Time",
              "Y": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Acocella 1972a - day 7 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Acocella 1972a - day 7 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)|Time",
              "Y": "Acocella 1972a - day 7 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin po 450 mg MD OD (7 days) - Plasma",
          "OriginText": "Rifampicin-Model2\nRifampicin po 450 mg MD OD (7 days)\n2019-05-13 13:49"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin po 450 mg MD OD (7 days)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0,
              "Max": 24.0,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "mg",
              "Dimension": "Amount",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0,
              "Max": 100.0,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin po 450 mg MD OD (7 days)-Rifampicin-Kidney-Urine-Amount in container",
              "X": "Time",
              "Y": "Rifampicin po 450 mg MD OD (7 days)|Organism|Kidney|Urine|Rifampicin",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Urine - agg. (n=5)-Rifampicin-Kidney-Urine-ArithmeticMean",
              "X": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Urine - agg. (n=5)|Time",
              "Y": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Urine - agg. (n=5)|ObservedData|Kidney|Urine|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin po 450 mg MD OD (7 days) - Urine",
          "OriginText": "Rifampicin-Model2\nRifampicin po 450 mg MD OD (7 days)\n2019-05-13 13:49"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin po 450 mg MD OD (7 days)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0,
              "Max": 24.0,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "mg",
              "Dimension": "Amount",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0,
              "Max": 25.0,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin po 450 mg MD OD (7 days)-Rifampicin-Gallbladder-Amount in container",
              "X": "Time",
              "Y": "Rifampicin po 450 mg MD OD (7 days)|Organism|Gallbladder|Rifampicin",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Bile - agg. (n=5)-Rifampicin-Liver-Undefined-ArithmeticMean",
              "X": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Bile - agg. (n=5)|Time",
              "Y": "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Bile - agg. (n=5)|ObservedData|Liver|Undefined|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin po 450 mg MD OD (7 days) - Bile",
          "OriginText": "Rifampicin-Model2\nRifampicin po 450 mg MD OD (7 days)\n2019-05-13 13:50"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin po 600 mg MD OD (7 days)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin po 600 mg MD OD (7 days)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)|Time",
              "Y": "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)|Time",
              "Y": "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)|Time",
              "Y": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Eon Labs Manufacturing, Inc. 1997 - 2X300mg Rifadine Tab - Rifampicin - PO - 600 mg - Plasma - agg. (n=36)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Eon Labs Manufacturing, Inc. 1997 - 2X300mg Rifadine Tab - Rifampicin - PO - 600 mg - Plasma - agg. (n=36)|Time",
              "Y": "Eon Labs Manufacturing, Inc. 1997 - 2X300mg Rifadine Tab - Rifampicin - PO - 600 mg - Plasma - agg. (n=36)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Baneyx 2014 - Day 4 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Baneyx 2014 - Day 4 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)|Time",
              "Y": "Baneyx 2014 - Day 4 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF8000",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Baneyx 2014 - Day 7 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Baneyx 2014 - Day 7 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)|Time",
              "Y": "Baneyx 2014 - Day 7 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#00C0C0",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin po 600 mg MD OD (7 days) - Plasma",
          "OriginText": "Rifampicin-Model\nRifampicin po 600 mg MD OD (7 days)\n2019-04-16 08:48"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin po 300 mg",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -0.5800238,
              "Max": 22.9674,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0214104,
              "Max": 9.406103,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin po 300 mg-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin po 300 mg|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Chouchane 1995 - Rimactan - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Chouchane 1995 - Rimactan - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)|Time",
              "Y": "Chouchane 1995 - Rimactan - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Chouchane 1995 - Rifampicin Generic - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Chouchane 1995 - Rifampicin Generic - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)|Time",
              "Y": "Chouchane 1995 - Rifampicin Generic - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Furesz 1970 - 300 mg - Rifampicin - PO - 300 mg - Serum - agg. (n=5)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Furesz 1970 - 300 mg - Rifampicin - PO - 300 mg - Serum - agg. (n=5)|Time",
              "Y": "Furesz 1970 - 300 mg - Rifampicin - PO - 300 mg - Serum - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin po 300 mg - Plasma"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin po 450 mg",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin po 450 mg-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin po 450 mg|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Blume 1989 - 450 mg REFERENZ - Rifampicin - PO - 450 mg - Plasma - agg. (n=8)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Blume 1989 - 450 mg REFERENZ - Rifampicin - PO - 450 mg - Plasma - agg. (n=8)|Time",
              "Y": "Blume 1989 - 450 mg REFERENZ - Rifampicin - PO - 450 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Furesz 1970 - 450 mg - Rifampicin - PO - 450 mg - Serum - agg. (n=13)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Furesz 1970 - 450 mg - Rifampicin - PO - 450 mg - Serum - agg. (n=13)|Time",
              "Y": "Furesz 1970 - 450 mg - Rifampicin - PO - 450 mg - Serum - agg. (n=13)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin po 450 mg - Plasma"
        }
      },
      {
        "SectionId": 23,
        "Project": "Rifampicin",
        "Simulation": "Rifampicin po 600 mg",
        "Plot": {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -0.8250712,
              "Max": 24.59259,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "g/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.03649712,
              "Max": 16.19482,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Rifampicin po 600 mg-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Rifampicin po 600 mg|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "LegendIndex": 1
              }
            },
            {
              "Name": "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)|Time",
              "Y": "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)|Time",
              "Y": "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)|Time",
              "Y": "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Furesz 1970 - 600 mg - Rifampicin - PO - 600 mg - Serum - agg. (n=12)-Rifampicin-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Furesz 1970 - 600 mg - Rifampicin - PO - 600 mg - Serum - agg. (n=12)|Time",
              "Y": "Furesz 1970 - 600 mg - Rifampicin - PO - 600 mg - Serum - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Rifampicin|ArithmeticMean",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Rifampicin po 600 mg - Plasma",
          "OriginText": "Rifampicin-Model2\nRifampicin po 600 mg\n2019-05-13 13:40"
        }
      }
    ]
  },
  "Inputs": [
    {
      "SectionId": 11,
      "Path": "Inputs/Midazolam/Compound/Midazolam.md"
    },
    {
      "SectionId": 16,
      "Path": "Inputs/Itraconazole/Compound/Itraconazole.md"
    },
    {
      "SectionId": 21,
      "Path": "Inputs/Rifampicin/Compound/Rifampicin.md"
    }
  ],
  "Sections": [
    {
      "Id": 1,
      "Title": "Introduction",
      "Content": "Content/Empty.md",
      "Sections": [
        {
          "Id": 2,
          "Title": "Objective",
          "Content": "Content/Qualification_DDI_CYP3A4_objective.md",
          "Sections": []
        },
        {
          "Id": 3,
          "Title": "CYP3A4 DDI Network",
          "Content": "Content/Qualification_DDI_CYP3A4_network_description.md",
          "Sections": []
        },
        {
          "Id": 4,
          "Title": "Qualification Workflow",
          "Content": "Content/Qualification_Workflow.md",
          "Sections": []
        }
      ]
    },
    {
      "Id": 5,
      "Title": "Qualification of Use Case CYP3A4-mediated DDI",
      "Content": "Content/Empty.md",
      "Sections": []
    },
    {
      "Id": 6,
      "Title": "Appendix",
      "Content": "Content/Empty.md",
      "Sections": [
        {
          "Id": 7,
          "Title": "Open Systems Pharmacology Suite (OSPS) Introduction",
          "Content": "Content/OSPS_Introduction.md",
          "Sections": []
        },
        {
          "Id": 8,
          "Title": "Mathematical Implementation of drug-drug interactions",
          "Content": "Content/Mathematical_Implementation_of_DDI.md",
          "Sections": []
        },
        {
          "Id": 9,
          "Title": "Evaluation of victim and perpetrator models",
          "Content": "Content/Intro_evaluation_victim_and_perpetrator_models.md",
          "Sections": [
            {
              "Id": 10,
              "Title": "Midazolam Model",
              "Content": "Content/Intro_Midazolam-model.md",
              "Sections": [
                {
                  "Id": 11,
                  "Title": "Midazolam input parameters",
                  "Content": "Content/Intro_Input_parameters.md",
                  "Sections": []
                },
                {
                  "Id": 12,
                  "Title": "Midazolam model evaluation",
                  "Content": "Content/Intro_Model_evaluation.md",
                  "Sections": [
                    {
                      "Id": 13,
                      "Title": "Midazolam concentration-time profiles",
                      "Content": "Content/Intro_Model_evaluation_CTprofiles.md",
                      "Sections": []
                    },
                    {
                      "Id": 14,
                      "Title": "Midazolam overall goodness of fit",
                      "Content": "Content/Intro_Model_evaluation_GOF.md",
                      "Sections": []
                    }
                  ]
                }
              ]
            },
            {
              "Id": 15,
              "Title": "Itraconazole Model",
              "Content": "Content/Intro_Itraconazole-model.md",
              "Sections": [
                {
                  "Id": 16,
                  "Title": "Itraconazole input parameters",
                  "Content": "Content/Intro_Input_parameters.md",
                  "Sections": []
                },
                {
                  "Id": 17,
                  "Title": "Itraconazole model evaluation",
                  "Content": "Content/Intro_Model_evaluation.md",
                  "Sections": [
                    {
                      "Id": 18,
                      "Title": "Itraconazole concentration-time profiles",
                      "Content": "Content/Intro_Model_evaluation_CTprofiles.md",
                      "Sections": []
                    },
                    {
                      "Id": 19,
                      "Title": "Itraconazole overall goodness of fit",
                      "Content": "Content/Intro_Model_evaluation_GOF.md",
                      "Sections": []
                    }
                  ]
                }
              ]
            },
            {
              "Id": 20,
              "Title": "Rifampicin Model",
              "Content": "Content/Intro_Rifampicin-model.md",
              "Sections": [
                {
                  "Id": 21,
                  "Title": "Rifampicin input parameters",
                  "Content": "Content/Intro_Input_parameters.md",
                  "Sections": []
                },
                {
                  "Id": 22,
                  "Title": "Rifampicin model evaluation",
                  "Content": "Content/Intro_Model_evaluation.md",
                  "Sections": [
                    {
                      "Id": 23,
                      "Title": "Rifampicin concentration-time profiles",
                      "Content": "Content/Intro_Model_evaluation_CTprofiles.md",
                      "Sections": []
                    },
                    {
                      "Id": 24,
                      "Title": "Rifampicin overall goodness of fit",
                      "Content": "Content/Intro_Model_evaluation_GOF.md",
                      "Sections": []
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "Id": 25,
          "Title": "Evaluation of DDI network (coupled perpetrator / victim simulations)",
          "Content": "Content/Intro_evaluation_DDI_network.md",
          "Sections": [
            {
              "Id": 26,
              "Title": "Itraconazole-midazolam DDI",
              "Content": "Content/Intro_Itraconazole-midazolam_DDI.md",
              "Sections": []
            },
            {
              "Id": 27,
              "Title": "Rifampicin-midazolam DDI",
              "Content": "Content/Intro_Rifampicin-midazolam_DDI.md",
              "Sections": []
            }
          ]
        }
      ]
    }
  ],
  "Intro": []
}